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Embryonic cells of many species polarise and the cell polarity is often important for the normal 
developmental progression. In the mouse embryo, the prototype of epithelial cell polarity, 
namely apico-basal polarisation, become established at the 2.5 days’ post-fertilisation, when 
the embryos are at the 8-cell stage. The formation of apical domain is necessary and sufficient 
for the first segregation of extra-embryonic and embryonic cell lineages, as well as the 
following up morphogenetic transitions, such as the blastocyst formation. This study aims to 
explore the molecular pathways triggering the first cell polarity establishment in the mouse 
embryo, and to reveal the mechanism that programmes the timing of this event in the mouse 
embryo.  
 
The results showed that cell polarity establishment during the 8-cell stage development can be 
divided into two major phases: in the first phase actomyosin complex became polarised to the 
cell-contact free surface; and in the second phase apical proteins recruited to the actomyosin 
enriched cell-contact free cortex, they further became centralised in the cell-contact free 
surface, excluding the local actomyosin meshwork, resulting in the formation of actomyosin 
ring. The activation and assembly of actomyosin meshwork during the first phase, but not its 
contractility, was essential for apical protein recruitment. Factors responsible for actin 
cytoskeleton reorganisation included Phospholipase C (PLC) – Protein Kinase C (PKC) 
pathway components, they directly activated actomyosin in the first phase through the Rho 
proteins such as RhoA.  
 
Further results showed that the apical protein centralisation step required a proximate 
transcriptional input that was induced by two transcription factors, Tfap2c and Tead4. RNAi 
and Genetic depletion of these two factors prevented apical protein centralisation and the final 
apical domain assembly. The protein expression profile indicated that Tfap2c and Tead4 
expression, and therefore their activity, were induced by zygotic genome activation. 
Significantly, overexpression of Tfap2c, Tead4, together with constitutively activated Rho 
proteins were sufficient to advance the timing of apical domain formation, indicating that the 
timer of cell polarity establishment at the 8-cell stage is set by the Rho proteins activation, and 
the zygotic transcriptional accumulation of Tfap2c and Tead4. Together, these results 
characterised the molecular events during the cell polarity establishment at the 8-cell stage 
mouse embryo, and identified the timing regulation of this event.   
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1.1 Pre-implantation development overview  
During the first four and a half days of mouse embryogenesis, the glycoprotein shell protected 
zygote transforms into a hollow structure termed the blastocyst, which is characterised by a 
huge fluid filled blastocoel surrounded by roughly a hundred cells. The blastocyst consists of 
three distinct cell lineages: the outermost layer is a primary epithelial tissue called 
Trophectoderm (TE), which consists of the majority of cells of a blastocyst and functions as a 
material exchange hub between the maternal environment and the embryonic tissues 
throughout gestation. A compact small ball of cells called the Inner Cell Mass (ICM) sits on 
the interior and on one side of the blastocyst, hosting two cell populations, the Epiblast (EPI) 
and the Primitive Endoderm (PrE), which give rise to the embryo proper and the yolk sac 
respectively (Bedzhov et al., 2014) (Figure 1.1). 
 
Building the blastocyst involves both morphogenetic and potency transitions. Totipotency, the 
ability of a cell to give rise to all lineages, becomes restricted with the establishment of cellular 
polarisation that happens at the 8-cell stage or 2.5 days’ post-fertilisation. The apical domains 
developed at the 8-cell stage are not inherited by all cells during the following cell divisions, 
leading to the generation of polar or apolar cells that ultimately engage different cell positions 
and fates. At the late morula stage the embryo is consisted of the outside and inside cells, which 
will become TE and ICM respectively. Despite that the cell position starts to diverge after the 
8-cell stage, the transcriptional segregation of TE and ICM precursors are progressive and the 
fate commitment only completes around the E3.5. This timing overlaps with the initiation of 
the next cell fate segregation event in which the ICM differentiates into EPI and PrE, 
accompanying with the cavitation event. All three lineages arise at E4.5 and by then the 
blastocyst is ready to implant into the uterus (Figure 1.1).  
 
Studying the molecular pathways governing cell fate specification during preimplantation 
embryogenesis has been challenging due to the scarcity of materials one can obtain from each 
small-sized embryo. The understanding of the molecular mechanism behind the 
preimplantation embryogenesis had been therefore largely relied on the embryological 
manipulations and the generation of genetic mutations. Early embryology studies suggest that 
the cell positioning and cell polarity cues are responsible for the early lineage segregation 
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(Johnson and Ziomek, 1981; Tarkowski and Wroblewska, 1967), and the generation of 
different gene knockout mouse identified important signalling pathways and transcription 
factors key for cell fate transitions. Nevertheless critical information is lacking to answer 
important questions such as how cellular morphogenetic changes crosstalk with lineage 
differentiation, as well as how the dynamics of different signalling pathway activities integrate 
and direct cell fate specification. The recent advance in bio-imaging methods, sequencing 
technology and the biophysics and mathematical analysis provided an unprecedented view into 
preimplantation development and helped to resolve many enduring developmental questions, 
particularly the processes segregating TE and ICM progenitors. The mechanical and chemical 
interactions linking cell polarity, cell position and cell fate have been recently revealed, yet 
many other important questions that are necessary to fully reveal the trajectory from 




Figure 1.1 Preimplantation mouse embryo development overview. Preimplantation 
development spans the first 4.5 days of mouse embryogenesis. It begins with a fertilised zygote, 
followed by three rounds of cleavage cell divisions. At the 8-cell stage the embryos undergo 
compaction during which cell-cell contacts are maximised. The individual cells establish apico-
basal polarity, with apical domains facing outwards (labelled in green). Following the 
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establishment of cell polarity, symmetric and asymmetric cell divisions generate outer 
polarised cells and inner apolar cells. The outer polarised cells ultimately give rise to 
Trophectoderm (TE), whereas the inner apolar cells give rise to Inner Cell Mass (ICM) that 
will further differentiate into Epiblast (EPI) and Primitive Endoderm (PrE). The cavitation 
event generates a fluid filled cavity in the middle (blastocoel) which completes the blastocyst 
structure. The embryos at the blastocyst stage then escape the zona pellucida (the outer shell 
labelled in grey), ready to implant into the uterus.  
 
 
1.2 Compaction and the establishment of cell polarisation 
After fertilisation, the zygote undergoes three rounds of cleavage divisions that increase cell 
numbers without affecting the total volume. At 2.5 post-fertilisation days, the eight 
morphologically identical cells flatten against each other, cell-cell boundaries become 
obscured and the cell contact-free area minimised (Pratt et al., 1982). Coinciding with 
compaction, each cell establishes an “apico-basal polarity" (Ziomek and Johnson, 1980), in 
which the cell-junctional proteins are exclusively enriched at the cell contacts (basal domain) 
(Clayton et al., 1999; Thomas et al., 2004), and the evolutionary conserved apical proteins 
aPKC and Pard6 become polarised to the cell contact-free surface (apical domain) (Hirate et 
al., 2013; Vinot et al., 2005). The embryo presents a radial pattern of polarity, with the basal 
domain localised on the inside of the embryo and apical domains facing outwards. This polarity 
pattern is highly conserved in evolution, as it also present in many non-mammalian early 
embryos such as C.elegans and Xenopus (Nance, 2014). Recent studies point to a critical role 
of compaction and cell polarity in regulating early mouse embryogenesis, as disturbance of 
these often leads to preimplantation developmental abnormalities (Kono et al., 2014; 
Stephenson et al., 2010).  
  
1.2.1 Compaction 
Cell adhesion bridges adjacent cells and facilitates multi-cellular scale interactions.  Thus it is 
important for both tissue morphogenesis and homeostasis (Dejana, 2004; Gumbiner, 2005). In 
the mouse embryo, cell compaction consolidates the blastomeres into an integrated entity, lays 
the foundations for subsequent morphogenetic events such as blastocyst formation (Ducibella 
and Anderson, 1975; Larue et al., 1994; Riethmacher et al., 1995), and plays an important role 
in cell fate specification events (Stephenson et al., 2010). Given the importance of compaction 
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for embryo progression, significant efforts were made to determine the mechanism triggering 
this first morphogenetic event. It is widely accepted that the Adherens Junction (AJ) complex, 
a universal and fundamental unit of cell-cell contacts, is critical for the compaction process. 
The basic elements composing the AJ include the transmembrane cadherin proteins, E-cadherin 
and beta/alpha-catenin (Hartsock and Nelson, 2008). Various different attempts to disrupt AJ 
proteins such as calcium-free medium culture (Pey et al., 1998), glycoprotein antibody 
incubation (Hyafil et al., 1980), RNAi or genetic gene trap targeting E-cadherin or alpha-
catenin (Torres et al., 1997; Wianny and Zernicka-Goetz, 2000) consistently abolished 
compaction at the 8-cell stage. No significant changes in the expression level of E-cadherin, 
nor any other AJ components can be detected before or after compaction (Ohsugi et al., 1996; 
Vestweber et al., 1987). Thus, the literature characterising upstream events driving cell 
compaction has focused primarily on the post-translational modifications of AJ proteins 
(Sefton et al., 1992; Vestweber et al., 1987). Some AJ components have indeed been reported 
to undergo certain post-translational modifications such as phosphorylation and the its level 
upregulates around the 8-cell sage, yet this seems dispensable for compaction as circumstances 
exist in which the compaction can happen without E-cadherin phosphorylation (Aghion et al., 
1994). Whether compaction is driven by transcription or post-translational modifications of AJ 
proteins per se remains so far unclear.  
  
Studies in other embryonic tissues or matured epithelial cells suggest that the level and spatial 
rearrangement of the surface tension are closely associated with the cell shape changes (Lecuit 
and Lenne, 2007; Miller and Davidson, 2013). In particular, the net balance between interfacial 
and cortical tension largely accounts for the cellular morphology (Winklbauer, 2015). The key 
regulator responsible for tension generation is the actomyosin meshwork, which is composed 
of actin and myosin II filaments, and is positioned underneath the plasma membrane (Munjal 
and Lecuit, 2014; Murrell et al., 2015). Theoretical modelling according to physical principles 
predicts that when cortical tension overrides interfacial tension, this can drive the junctional 
membranes to expand and flatten against each other (Manning et al., 2010). This is commonly 
the case when cell-contacts become established and cortical tension interacts with the 
actomyosin network to reduce the interfacial tension. Such mechanism appears largely true for 
mouse embryo compaction, as it has recently been shown that during the 8-cell stage 
development the actomyosin network becomes apically polarised and accompanies cell-contact 
elongation and thereby compaction. More importantly, when the overall surface tension is 
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reduced, through inhibition of the contractility of myosin II, cell compaction does not occur 
(Maitre et al., 2015).  This result is reminiscent of the theoretical model suggesting that 
compaction is driven by intracellular mechanics and that actomyosin apical polarisation is a 
key event in this process.  
  
Alongside the role of differential surface tension in driving cell compaction, morphological 
changes in the membrane involving the formation of protrusions also contributes to cell 
compaction. A recent study using advanced time-lapse imaging methods, found that one type 
of membrane protrusion named filopodia substantially formed during cell compaction between 
adjacent blastomeres. AJ proteins, such as E-cadherin, alpha-catenin and beta-catenin, as well 
as a special myosin motor protein, myosin X, have all been identified as components of the 
filopodia (Fierro-Gonzalez et al., 2013). Filopodia have been documented previously in 
cultured cells and are associated with cell migration, but their function in the context of 
development is not clear (Nishita et al., 2006). These filopodia form during compaction, 
actively extend at the points of contact with adjacent blastomeres, and then retract prior to cell 
divisions (Fierro-Gonzalez et al., 2013). Laser ablation of filopodia leads to the failure of cell 
compaction, while conversely, induction of premature formation of filopodia by 
overexpression of myosin X induces premature compaction (Fierro-Gonzalez et al., 2013). This 
suggests that these structures assist the compaction process, presumably by promoting the 
binding of trans-AJ molecules and thus the establishment of new AJ across cell-membranes 
(Fierro-Gonzalez et al., 2013; White and Plachta, 2015) (Figure 1.3).   
  
In brief, recent studies suggest that actomyosin tension, together with the formation of 
membrane specialised structures activate compaction process at the 8-cell stage.  
  
1.2.2 Apico-basal polarity establishment 
Similar to most other embryonic model systems, mouse embryonic cells are polarised but only 
after the 8-cell stage (Johnson and Ziomek, 1981; Nance, 2014). As mentioned earlier, the 
time-window of polarity overlaps with that of compaction (Ziomek and Johnson, 1980) and 
thus these two processes are thought to be correlated.  Proteins from many different types of 
junctions localise to the basal domain but not all of them are completely functional at the 8-
cell stage. These include: the AJ proteins; the gap junction proteins such as connexin43; and 
some but not all tight junction proteins, such as Jam-1 (also named F11r) (De Sousa et al., 1993; 
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Ducibella et al., 1975; Thomas et al., 2004). Meanwhile, a handful of conserved epithelial 
apical polarity proteins are also enriched at the apical domain. Typical examples include: the 
functional Par complex, which consists of a scaffold protein Pard6 and a kinase protein atypical 
Protein Kinase C (aPKC) (Vinot et al., 2005), and in general drives apical domain 
differentiation; the ERM protein family, which controls microvilli formation and acts as a 
linker between the plasma membrane and Filamentous actin (F-actin) (Louvet et al., 1996); 
various cytoskeleton components, such as actin and the microtubule network (Johnson and 
Maro, 1984; Maro et al., 1991).  The changes in molecular distribution are coupled with 
ultracellular structural changes. Consistent with the apical enrichment of ERM family proteins 
and F-actin, the microvilli, a cluster of specific cellular membrane protrusions which function 
to facilitate the ion exchange between the intracellular and intercellular environments, are also 
polarised to the cell contact-free surface (Reeve and Ziomek, 1981).  
 
 
Figure 1.2 The establishment of cell polarisation at the 8-cell stage of embryonic 
development. During the 8-cell stage, the cell contacts enriched by E-cadherin are polarised 
to the cell contacts site and become elongated (basal domain), resulting in the close apposition 
between adjacent blastomeres. Concomitantly, the Par complex, including aPKC, Pard6 and 
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ERM family members such as Ezrin, becomes recruited to the cell contact-free surface, 
denoting the apical domain.  
 
Apico-basal polarisation is established at the 8-cell stage and drives the commencement of the 
epithelisation process that takes place during TE differentiation. At the 16-32 cell stage, the 
apical domains start to expand to the cell-junctions where they couple to newly recruited tight 
junction proteins such as ZO-1 and Cingulin, a process that is termed “apical domain zippering” 
(Zenker et al., 2018). Tight junctions become fully matured at the late morula stage with the 
recruitment of Claudin and Occuldin (Eckert and Fleming, 2008). Tight junction maturation 
also coincidence with the recruitment of membrane Na+ K+ ATPase pumps, with which the 
embryo starts to cavitate. Desmosomes, another important type of junctions in epithelial cells, 
can only be detected from the blastocyst stage in the TE cells (Fleming et al., 1991). Therefore, 
the epithelialisation process of the outside TE starts from the 8-cell stage but is only completed 
at the blastocyst stage (Fleming et al., 1989).  
  
Epithelisation at the 8-cell stage mouse embryo begins with the establishment of polarity of a 
small group of non-polarised cells and extends to the subsequent process of TE maturation. It 
is a unique in vivo model for the study of de novo cell polarity establishment as well as that of 
initiation of epithelisation. However, in comparison to other model systems such as C.elegans 
and Drosophila our knowledge of cell polarity establishment in the early mouse embryo is 
limited (Nance, 2014; St Johnston and Ahringer, 2010).  
  
1.3 Symmetric and asymmetric cell divisions, and two models of cell fate 
decisions  
The initiation of epithelial polarity at the 8-cell stage is a critical event for embryonic 
progression as it facilitates cellular diversity and thereby lineage differentiation, through 
symmetric or asymmetric cell divisions. This model has recently been illustrated in the context 
of mouse embryo development, but is also likely to be conserved in other mammalian species, 
as its key components show similar distribution patterns in human and bovine embryos 
(Frankenberg et al., 2016; Kuijk et al., 2012).   
  
In the mouse embryo at the time of cytokinesis which follows on from the 8-cell stage, as the 
embryonic cells polarise, the apical domain can be distributed in two different ways. On one 
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hand, the apical domain may be equally partitioned by the cleavage plane, in which case it is 
inherited equally by the two daughter cells, resulting in the formation of two polarised cells or 
two polar cells. On the other hand, the cell cleavage planes may incline in which case apical 
domains are assigned to only one side, permitting the generation of two cells that differ in their 
cell polarisation status, thus a polar and an apolar cell. In the former case the process is termed 
symmetric cell division while in the latter case it is termed asymmetric (Figure 1.3) (Bedzhov 




Figure 1.3 Internalisation of apolar cells during 8-16 cell division. During the 8-16 cell 
stage, the cells can divide in two different ways: 1) in symmetric cell division the apical domain 
is equally inherited by the two daughter cells (labelled in pink). The presence of the apical 
domain antagonises actomyosin contractility and therefore reduces cortical tension, allowing 
the two daughter cells to remain outside. 2) In asymmetric cell division, one of the daughter 
cells appears apolar and therefore displays high actomyosin contractility and cortical tension, 
and is internalised as a result of the net cortical tension difference with its neighbouring cells.  
 
The difference in cell polarity between polar and apolar cells relates to subsequent differences 
in cell position and fate. Specifically, the polarised cells are positioned on the outside and 
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become TE, whereas the apolar cells are positioned on the inside and are specified as 
pluripotent ICM. As both the cell polarity conditions as well as the cell position seem to 
correlate with cell fate, two models namely the inside-outside model and the cell polarity model, 
have been proposed to explain the mechanism segregating TE and ICM cell fate.  
  
1.3.1 Inside-outside model 
The inside-outside model originated from an early observation that when cell numbers were 
not sufficient for correct positioning of cells on the inside of a blastocyst, such as in the case 
of an isolated 8-cell stage blastomere allowed to develop to blastocyst stage, all cells would 
specify as TE (Tarkowski and Wroblewska, 1967). Tarkowski et al., therefore proposed that 
the cell position endows the cells with distinct external environment which specifies their fate. 
This hypothesis is further supported by the experimental observation that when the cell position 
of inside and outside cells in 16-cell to 32-cell stage embryos were experimentally reversed, 
the cells altered their fate in response to the new positions accordingly (Handyside, 1978; 
Spindle, 1978). Although the determinant of inside-outside cell positioning remains unclear, 
as does the initial cue that breaks symmetry to generate different cell positions, this model has 
been highly influential for a certain period due to its simplicity and its strength in explaining 
experimental observations. The discovery of new transcription factors that are responsible for 
specifying different lineages however bring some doubts to this model, as those transcription 
factors start to express non-correlated with cell positions initially (Anani et al., 2014; Dietrich 
and Hiiragi, 2007). Some other cues seem to come into play to influence cell fate before the 
cells settle their positions.  
  
1.3.2 Cell polarity model 
By dissecting single 8-cell stage blastomeres and examining their polarisation status using 
Concanavalin A, it was determined that the 8-16 cell stage divisions generate two populations 
of cells, one of which appears polarised and the other apolar (Johnson and Ziomek, 1981a 
(Johnson and Ziomek, 1981; Ziomek and Johnson, 1981). Together with the observation that 
the polarised cells always localise to the outside of the embryo while the apolar cells are 
enclosed (Handyside, 1981; Reeve and Ziomek, 1981; Ziomek and Johnson, 1981), a second 
hypothesis was raised, according to which the differential inheritance of polarised domains 
leads to the formation of TE and ICM cells. 
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The latter cell polarity model is not independent of the former inside-outside model but rather 
it is complementary to it. However, the intermediate steps between the asymmetric assignment 
of the apical domains and the final allocation of cell position remained undetermined (Johnson 
and Ziomek, 1981a). That is, what allows the polarised cells to maintain their outside position 
and what leads the apolar cells to the inside? Thanks to the advance of time-lapse imaging 
techniques and the introduction of mechanical principles, this question has been recently 
addressed. Moreover, the generation of several knockout mice has aided in the discovery of the 
critical modulators of TE/ICM segregation. Current literature allows us to draw a relatively 
complete picture of TE and ICM lineage segregation, with the inclusion of both of the two 
aforementioned models. 
  
1.4 The mechanisms behind the first cell fate decision  
  
1.4.1 Active cell internalisation directed by cellular surface tension settles the final cell 
position 
It has always been assumed that the inside cells adopt their position directly by asymmetric 
cell divisions, that is, the spindle orientation is almost perpendicular to the apical domain and 
thus the cell is directly pushed to the inside (Rossant and Tam, 2009; Zernicka-Goetz et al., 
2009). In the effort to discern the link between cell polarity and cell position, another interesting 
observation from the work describing the cell polarity model should be considered. Despite 
reports that a single 8-cell blastomere preferentially divided asymmetrically (82%) (Johnson 
and Ziomek, 1981a), and therefore one would expect around 6 apolar cells to arise from the 8-
16 cell stage division, the average number of inside cells at the 16-cell stage was found to be 
only 2-3 (Anani et al., 2014; Morris et al., 2010). Arguably, in the case of the isolated 
blastomere the lack of cell-cell contacts in the environment may have modulated the ratio of 
division patterns which would explain the difference in number.  Yet although recent results 
using intact embryos showed that the frequency of asymmetric cell divisions is slightly lower 
than that in isolated couplets, it is still too high to explain the number of inside cells (around 
60%) ((Anani et al., 2014; Humiecka et al., 2017).  It thus seems unlikely that asymmetric cell 
divisions would directly allocate the apolar cells to the inside. In order for this process to be 
confidently captured an approach allowing the visualisation of the global cell behaviour is 
necessary. A recent study utilised high resolution confocal microscopy, combined with a 3D 
membrane segmentation technique to demonstrate that, in the majority of asymmetric cell 
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divisions, the spindle is not oriented along the radial axis of cell polarity in each cell, but rather 
it is randomised (McDole et al., 2011; Samarage et al., 2015; Watanabe et al., 2014). As a 
result, many apolar cells are left on the outside of the embryo, but from the 12-cell stage 
onwards, 2-3 cells are selectively engulfed by the embryo, via a process known as 
"internalisation" (Samarage et al., 2015). So what triggers cell internalisation and why are only 
2-3 cells engulfed? The key player is again the actomyosin complex and the resulting surface 
tension it generates. In the first instance, it was shown that the active actomyosin complex 
appears asymmetric between polar and apolar cells in both 16-cell couplets and intact embryos 
(Anani et al., 2014; Samarage et al., 2015).  Specifically, surface tension is high in apolar cells 
and low in polar cells, and as a result when a polar cell encounters an apolar cell the membrane 
of the polar cell will move over the apolar cell, leading to an “entosis” like behaviour (Figure 
1.3) (Anani et al., 2014). Similar results can be expected in an intact embryo, especially in 
cases where the newly formed apolar cells are surrounded by polar cells. However when too 
many apolar cells appose nearby, the engulfment purely depends on the differential surface 
tension. A successful engulfment of apolar cells will only happen when the difference in 
surface tension is above 1.5 fold (Maitre et al., 2016), thus explaining why only a small 
proportion of cells can be engulfed. In support of the model, reducing actomyosin activity by 
for example depletion of myosin or inhibition of myosin phosphorylation, blocked cell 
internalisation, and led to subsequent cell fate alteration (Figure 1.3) (Maitre et al., 2016; 
Samarage et al., 2015).  
  
Together this evidence points to actomyosin as a critical regulator of cell internalisation, yet 
the number of cells that can be engulfed depends on both the surrounding environment and the 
geometrical limitations of the inner space.  
  
1.4.2 The apical domain suppresses actomyosin contractility and is a necessary and 
sufficient condition for TE fate induction 
How does the activity of actomyosin differ in polar and apolar cells? As it appears that the 
apical domain activity is negatively correlated with the level of actomyosin, it would be 
reasonable to assume that the apical domain suppresses actomyosin activity. This has proven 
to be largely true: once the apical domain is established, it occupies a proportion of the cell 
contact-free surface between the 8-16 cell stage and actomyosin activity appears to be lower 
on the inside of the apical domain than the periphery. However, the depletion of apical domain 
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components, such as aPKC isoforms, leads to homogeneous actomyosin activity over the entire 
cell contact-free surface, indicating an aPKC mediated inhibition of actomyosing activity  
(Maitre et al., 2016).  
  
Besides the role of actomyosin in mediating cell internalisation, it is clear that the differential 
allocation of the apical domain also influences the cell position. Polar cells remain on the 
outside of the embryo as a result of a lack of actomyosin activity, while the apolar cells have 
the potential to localise to the inside, but this process is dependent the neighbouring 
environment. Cells that are not engulfed will then re-polarise and remain on the outside. 
  
But is the apical domain really the key modulator in directing the cells to the TE fate? To 
unequivocally clarify this point, an apical domain transplantation experiment was performed. 
In this experiment, the apical domain from a polarised 8-cell stage blastomere was grafted to 
the apolar cells of a 16-cell stage embryo. The results indicate that the exogenous apical domain 
was sufficient to direct the apolar host cells to upregulate Cdx2 expression and thus become 
specified as TE progenitors (Korotkevich et al., 2017). 
  
Thus far it is clear that the cell polarity model and the inside-outside model can be reconciled. 
The apical domain is either symmetrically or asymmetrically assigned to the daughter cells, 
leading to the generation of polar and apolar cells. The cells tend to have high actomyosin 
contractility yet this is inhibited by the apical domain. As a result, the apolar cells when 
surrounded by polar cells, present with a greater surface tension, which results in the 
engulfment of these cells to the inside of the embryo. When positioned inside, E-cadherin 
covers all cell membranes and therefore apical domains can no longer be re-generated, which 
restricts the fate of these cells to the ICM.  
 
1.4.3 Polarity couples a mechano-sensing mechanism to regulate Hippo pathway 
activity and determine inside and outside cell fates. 
The specification of TE and ICM fate is reliant on the activation of a lineage specific 
transcriptional network. The TE transcriptional network is established by several master 
transcription factors (TF) such as Cdx2, Gata3, Elf5 and Eomes (Latos et al., 2015; Niwa et al., 
2005; Ralston et al., 2010; Russ et al., 2000). Of these, Cdx2 and Gata3 function during TE 
specification at the preimplantation stage, while Elf and Eomes are important for maintaining 
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the extraembryonic ectoderm identity in the post-implantation embryo. The knockout of 
zygotic Cdx2 results in TE differentiation defects, as a result of which the embryos collapse 
soon after implantation (Strumpf et al., 2005). The pluripotent ICM state, on the other hand, is 
stablished by pluripotency factors including Nanog (Mitsui et al., 2003), Sox2 (Avilion et al., 
2003) and Oct4 (Nichols et al., 1998), all of which are known to be essential in the self-renewal 
of pluripotent embryonic stem cells (Kashyap et al., 2009; Loh et al., 2006). In the embryo, the 
transcriptional network responsible for TE fate specification, inhibits the ICM cell fate and 
restricts the pluripotent ICM progenitors to the inside of the embryo (Dietrich and Hiiragi 
(Dietrich and Hiiragi, 2007; Strumpf et al., 2005). Specifically, both Cdx2 and Gata3 
expression are limited to the outside cells from the 16-cell stage onwards, and before ICM 
markers are restricted to the inside (Dietrich and Hiiragi, 2007; Ralston et al., 2010). The 
knockout of TE factors, such as Cdx2, leads to the expression of ICM markers by the outside 
cells (Strumpf et al., 2005). This suggests that the cells may adopt the ICM cell fate by default, 
but subsequently adopt the TE fate as a result of repression of the ICM transcriptional network 
by the expression of TE regulators. 
  
What activates TE regulators in the outside cells? Recently, the events upstream of this 
pathway have been uncovered. Specifically, the transcription factor Tead4, an important 
regulator of Hippo pathway activity (Zhao et al., 2008), is responsible for both Cdx2 and Gata3 
zygotic activation. The knockout of Tead4 leads to a complete failure of TE specification, 
accompanied by a dramatic down-regulation of Cdx2 and Gata3 (Nishioka et al., 2008; Yagi 
et al., 2007). However, the expression of Tead4 itself is not exclusively restricted to the outside 
cells but is rather homogeneous in all cells of the late morula, indicating that other factors are 
involved in providing the cells with spatial information (Nishioka et al., 2008). According to 
the properties of the Hippo pathway described in Drosophila, Tead4 does not bind DNA alone 
but requires a partner termed Yap/Taz (Huang et al., 2005). Unlike Tead4, Yap/Taz appears to 
be localised specifically in the nucleus of the outside cells (Nishioka et al., 2009). It thus seems 
that the nuclear translocation of Yap/Taz is the key for TE specification. Then what restricts 
nuclear Yap/Taz to the outside cells? As expected, the apical domain plays a decisive role. The 
down-regulation of essential apical components, such as the knockdown of Pard6b (Alarcon, 
2010), the overexpression of aPKC dominant negative forms (Hirate et al., 2013), or the 
depletion of Cdc42 (Korotkevich et al., 2017), consistently leads to the loss of nuclear Yap in 
the outside cells, and the subsequent repression of Cdx2 in the whole embryo. Conversely, the 
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transplantation of an exogenous apical domain to the apolar 16-cell stage embryo promotes 
nuclear localisation of Yap in those cells (Korotkevich et al., 2017). Together, these results 
consistently demonstrate that the presence of the apical domain directs Yap/Taz translocation 
to the nucleus where it cooperates with Tead4 to activate the TE transcriptional program.  
  
So what links the apical domain to Yap/Taz nuclear translocation?  It seems that both 
biochemical and mechanical cues come into play. In a study of cultured cells, the AMOT 
protein family, including Amot and its homologue Amotl1, were shown to inhibit the nuclear 
translocation of Yap by promoting its phosphorylation (Zhao et al., 2011).  It appears that 
AMOT family proteins function in a similar manner in the mouse embryo and in fact they serve 
as the critical linker between the apical domain and Yap nuclear localisation. The 
downregulation of Amot and Amotl2 leads to Yap nuclear localisation in the inside cells, and 
accordingly results in the ectopic Cdx2 expression on the inside (Hirate et al., 2013; Leung and 
Zernicka-Goetz, 2013). As expected, AMOT proteins present differential activities between 
the inside and outside cells and this is under the regulation of the apical domain. In the inside 
cells where the apical domain is missing, AMOT proteins bind to the cell contacts where they 
get phosphorylated and become active, sequestering Yap to the cytoplasm; in the outside cells, 
the apical domain, presumably due to aPKC, traps AMOT proteins from the cell contacts to 
the apical side, thus allowing Yap to translocate to the nucleus (Hirate et al., 2013; Leung and 
Zernicka-Goetz, 2013).  
 
 Recent studies have shown that Yap/Taz can also function as a mechano-sensor and its 
nuclear/cytoplasm localisation can be controlled by upstream mechanical cues (Halder et al., 
2012). Interestingly, such a pathway also functions during TE/ICM fate segregation. 
Specifically, a couple of recent studies have demonstrated that during the asymmetric cell 
divisions, the apolar cells not only adopt higher actomyosin contractility, but also present 
cytoplasmic Yap (Anani et al., 2014; Maitre et al., 2016).  On the other hand, in the polar cells 
which have an apical domain, Yap appears in the nucleus before the final cell position is settled 
(Anani et al., 2014).  As mentioned earlier, the apolar cells adopt a greater actomyosin 
contractility and therefore a higher surface tension, and it appears that Yap is localised 
deferentially prior to the determination of cell position, and this process is controlled directly 
by actomyosin contractility, rather than the cell contact environment. The inhibition of 
actomyosin contractility by blebbstatin treatment results in homogeneity of the Yap 
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nuclear/cytoplasm ratio between the apolar and polar cells, and cell differentiation is blocked 
(Maitre et al., 2016).  
  
The precise mechanism behind Yap localisation remains unclear. That is, it is unknown 
whether mechanical cues controlling Yap localisation are AMOT protein dependent, and 
whether the time window during which surface tension controls differential Yap localisation is 
specific to the early morula, as in the later stages symmetric and asymmetric cell divisions 




Figure 1.4 The Hippo pathway directs polarised outer cells to become TE. At the morula 
stage, in the outer polarised cells the Par complex (including Pard6 and aPKC) recruits and 
inhibits Amot/Amotl2 which blocks the activation of Lats1/2 kinase. Yap can diffuse to the 
nucleus to form the Tead4/Yap transcription complex, which activates Cdx2 expression. The 
Par complex activity is partially maintained by ROCK activity. In the inner apolar cells, 
Amot/Amolt2 binds to the AJ and activates the Lats1/2 kinase. The Lats1/2 kinase 
phosphorylates Yap and therefore blocks its transportation to the nucleus. The lack of activated 
Tead4/Yap transcription machinery induces the expression of pluripotency factors (such as 
Oct4) that direct the cells to the ICM fate.  
 
In conclusion, recent studies have shed light on the mechanisms governing the first cell fate 
decision, where the TE and ICM lineages are segregated in the early mouse embryo. Briefly, 
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the apical domains seem to drive the process of segregation of the TE and ICM progenitors, 
through activation of the TE transcriptional network in the polarised cells via the inhibition of 
the Hippo pathway. Subsequently, cell position, which is determined by differential 
actomyosin activity and surface tension prompts the allocation of the appropriate cell fate.  
  
  
1.5 Project Aim 
  
Dissecting the mechanisms driving the first cell fate decision is a complex but fundamental 
step in understanding preimplantation mouse embryo development. Although recent studies 
have addressed questions pertaining to the correlation between cell position, cell polarity and 
cell fate, many fundamental questions remain open, such as what triggers cell polarity 
establishment, and precisely how species specific timing of such events is regulated. Thus, the 
current project aims to investigate the possible mechanisms driving cell polarity establishment, 
and address the question of how cell polarity timing is regulated. The first part of the results 
will mainly address the molecular cascades required for cell polarity establishment at the 8-
cell stage. The second chapter will discuss the transcriptional requirement for cell polarity 
establishment and the possible connection between these programs and the timing of cell 





















2 Material and Methods 
 
2.1 Animals 
This research has been carried out following regulations of the Animals (Scientific Procedures) 
Act 1986 - Amendment Regulations 2012 - reviewed by the University of Cambridge Animal 
Welfare and Ethical Review Body. Embryos were collected from F1 females (C57BI6xCBA) 
that had been superovulated by injection of 7.5 IU of pregnant mares’ serum gonadotropin 
followed by human chorionic gonadotropin (Intervet) 48 h later. F1 females were mated with 
F1 males. 
 
2.2 Embryo culture and inhibitor treatments 
Embryos were recovered at the zygote or 2-cell stage in M2 medium and subsequently 
transferred to KSOM medium for long-term culture, as described previously (Graham et al., 
2014).  
For staging the 8-cell stage embryo development, the cytokinesis time-point of the last cell of 
the 4-cell stage embryo has been used as a reference, embryos within 1-2 hours’ post-division 
have been considered as “early 8-cell stage”; 3-4 hours’ post-division as “mid 8-cell stage” and 
6-9 hours’ post-division as “late 8-cell stage”.   
Inhibitor treatment: Puromycin (Invivogen, ant-pr-1) was diluted in KSOM to a working 
concentration of 10µg/ml. Cycloheximide (Sigma-Aldrich, C7698) was dissolved in DMSO 
and diluted in KSOM to a working concentration of 20µg/ml. 5,6-Dichlorobenzimidazole 1-b-
D-ribofuranoside (DRB; Sigma-Aldrich, D1916) and Tritolide (Cayman Chemical, 
CAY11973) were dissolved in DMSO and diluted in KSOM to a working concentration of 
50µM (DRB) or 5µM (Triptolide). D-erythro-sphingosine C-18 (2.5 µM; Caymanchem; in 
DMSO); Calphostin C (200 nM; Santa Cruz Biotechnology; in DMSO); U73122 (4.5–7.5 µM; 
Caymanchem; in DMSO); blebbistatin (25 µM; Sigma-Aldrich; in DMSO); ML-7 (20 µM; 
Sigma-Aldrich; in DMSO); Y-27632 (20 µM; Stemcell Technologies); C3-transferase (7 µg/ml; 
Cytoskeleton; in distilled water; the zona pellucida of 4–8-cell embryos was removed as 
described; 1-oleoyl-2-acetyl-sn-glycerol (OAG) (200 µM; Caymanchem; in DMSO), 
Latrunculin B (15 µM; Abcam; in DMSO). For the control groups, the same dilutions of the 
vectors of different inhibitors were added to the medium. 
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2.3 Blastomere resection 
The resection procedure was performed as previously described (31). Briefly, the zona 
pellucida was removed for both 2-cell stage and 4-cell stage embryos. Embryos were 
transferred to a 1% agarose coated petri-dish covered by M2-medium containing 2µM 
Cytochalasin D (Sigma-Aldrich, C8273) prior to the resection procedures. For the 2-cell stage 
embryo, the embryo was first elongated by using a thin glass capillary with a flame-polished 
end. One of the blastomeres was resected using a thin glass needle, leaving approximately 30-
40% of the cytoplasm (cytoplast) attached to its sister cell. For the 4-cell stage resection, the 4 
blastomeres were first transferred to Calcium-Magnesium free M2 medium for 5 min and cells 
were disassociated by gently pipetting, as previously described (Graham et al., 2014). All four 
blastomeres were elongated using a thin glass capillary, and only two were resected (Figure 
4.3 B, E). The resected and control cells were transferred to M2 medium immediately after 
resection. The whole resection process for each embryo took up to 5 min with a survival rate 
greater than 80%. 
   
2.4 Microinjection 
Microinjection was carried out as described previously. In brief, embryos were placed in M2 
medium on a glass slide with a depression and covered by a drop of mineral oil. Microinjection 
was performed with an Eppendorf Femtojet Microinjector. Negative capacitance was used to 
facilitate penetration through the membrane. dsRNA was injected at a concentration of 1µg/µl. 
Synthetic mRNAs were injected at the following concentration: PLCδ1-PH-Ruby (1 µg/µl); 
Ruby (900 g/µl); GFP-MRLC (600 ng/µl); PKCɑ-A25E (200 ng/µl); CIBN-Zsgreen-CAAX 
(400 ng/µl); CIBN-Zsgreen (400 ng/µl); CRY2-mCherry-PKC-KD (500 ng/µl); GFP-Myl12b-
T18DS19D (600 ng/µl); Raichu-RhoA-CR (600 ng/µl); Clover (200 ng/µl); mRuby2 
(200 ng/µl); RhoA-Q63L (150 ng/µl (for experiments in Chapter III; 3ng/ul for experiments in 
Chapter IV)); CRY2-mCherry-RhoA-Q63L-C190R (600 ng/µl); CRY2-mCherry (500 ng/µl); 
Ezrin-Ruby (400 ng/µl); Ezrin-Venus (400ng/µl);LifeAct-eGFP (300 ng/µl). Tfap2c (15ng/µl); 
Tead4 (15ng/µl); Cas9 (100ng/µl). All sgRNAs were injected at 25ng/µl.  
 
2.5 Preparation of DNA Constructs  
pRN3P was used as the vector for all constructs as previously described (Zernicka-Goetz et al., 
1997). To construct PLCδ1-PH-Ruby. The PH domain of Plcδ1 was PCR-amplified from 
pBSK-Plcδ1-PH-eGFP40 (Varnai and Balla, 1998) and cloned into the pRN3P vector. pRN3P-
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Ruby and pRN3p-GFP-Myl12b are used as previously described (Ajduk et al., 2011). pRN3p-
GFP-Myl12b-T18DS19D is made by site-directed mutagenesis using GFP-Myl12b as a 
template. RhoA-Q63L was PCR amplified from PCR-amplified from pRK5myc-RhoA-L63 
and cloned into pRN3p. To construct pRN3p-CIBN-Zsgreen, The CIBN domain was PCR-
amplified from pCMV-CIB1-mCerulean-MP (gift of Won Do Heo (Addgene plasmid 
#58366)). The Zsgreen was subcloned from pZsgreen-C1 (Clontech) and inserted downstream 
of CIBN. The CAAX motif of K-Ras was PCR-amplified from mouse liver complementary 
DNA (cDNA), and inserted downstream of Zsgreen to make pRN3p-CIBN-Zsgreen-CAAX. 
To construct pRN3p-CRY2-mCheery-PKC-KD, CRY2 domain and the mCherry coding 
sequence were subcloned from pCMV-CRY2-mCherry (gift of Won Do Heo (Addgene 
plasmid #58368)) into pRN3P; the kinase domain of PKCɑ (337-673aa) was PCR-amplified 
from pMTH-PKCalpha (gift of Frederic Mushinski (Addgene plasmid #8409)) and inserted 
downstream of CRY2-mCherry.  To construct pRN3p-PKC	ɑ-A25E, the coding sequence of 
Prkca was PCR-amplified from pMTH-PKCalpha and cloned into pRN3P. The A25E mutation 
was generated by site-directed mutagenesis. pRN3p-Raichu-RhoA-CR was made by PCR 
amplification of Raichu-RhoA-CR from pCAGGS-Raichu-RhoA-CR (gift from Michael Lin 
(Addgene plasmid #40258)) and inserted into pRN3P. pRN3p-Clover and pRN3p-mRuby2 
were made by PCR amplifying Clover and mRuby2 fragments from pCAGGS-Raichu-RhoA-
CR and inserted into pRN3P vector. CRY2-mCherry-RhoA-Q63L-C190R was made by site-
driected mutagenesis (using pRN3p-RhoA-Q63L as a template) and inserted into pRN3p-
CRY2-mCherry downstream of mCherry. To construct Ezrin-Ruby and Ezrin-Venus, Ezrin-
Ruby: Ruby was inserted into pRN3P, Ezrin was PCR-amplified from mouse adult kidney 
cDNA and inserted upstream of Ruby or Venus. To construct LifeAct-eGFP or LifeAct-Ruby, 
LifeAct peptide coding sequence was cloned into pRN3P plasmid, eGFP coding sequence or 
Ruby coding sequence were subcloned and inserted downstream of LifeAct. To construct 
pRN3p-Tead4, Tead4 was amplified from mouse kidney cDNA and cloned into pRN3p vector. 
To construct pRN3p-Tfap2c, Tfap2c cDNA was purchased from Origene (MR207174) and 
cloned into the pRN3p vector. pRN3p-Cas9 was a gift of J. Na (Tsinghua University, School 
of Medicine). All primers for constructs preparation are listed as below: 
  
Table 2.1 Primer sequences for constructs preparation 
Primer name Sequence (5' to 3') 
Tead4-BamHI-F TTACGGATCCTATGACCTCCAACGAGTGGAG 




























2.6 mRNA, dsRNA, sgRNA preparation 
For mRNA preparation, constructs for each mRNA were linearised using a restriction site 
downstream of poly-A region. In vitro transcription was performed using the mMessage 
mMachine T3 kit (Thermo Fisher, AM1348) following the manufacturer’s instructions. 
mRNAs were purified using lithium chloride precipitation method.  
For sgRNA preparation, the sequence of sgRNAs were designed using CRISPR design tool 
website (http://cirpsr.mit.edu). The DNA fragment containing T7 promoter, crRNA and 
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sgRNA sequence were amplified using Geneart gRNA kit (Thermo Fisher, A29377). sgRNAs 
were in vitro transcribed and purified using gRNA Clean Up Kit (Thermo Fisher, A29377), 
following manufactuer’s instructions. All primers for making sgRNAs were listed below: 
 
Table 2.2 Primers sequence for sgRNAs preparation 















All dsRNAs were designed using the E-RNAi website (Horn and Boutros, 2010) and were 350-
500bp in length. The specific targeting regions for each dsRNA were amplified from a mixture 
of mouse kidney, lung, liver cDNAs.  The in vitro transcription reactions were performed using 
the MEGAscript T7 transcription kit (Thermo Fisher, AM1334) following the manufacturer’s 
instructions. dsRNAs were purified by lithium chloride precipitation. All primers for dsRNA 
preparation are listed below: 
 
Table 2.3 Primers for dsRNA preparation 













































































































































































































































































































































































Embryos were fixed in 4% PFA at room temperature for 20min, and washed in PBST (0.1% 
Tween in PBS) three times. Embryos were permeabilised in 0.5% Triton X-100 in PBS for 
20 min at room temperature, washed in PBST three times, transferred to blocking solution (3% 
bovine serum albumin) for 2h and incubated with primary antibodies (diluted in blocking 
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solution) at 4 °C overnight. After the incubation, embryos were washed in PBST and incubated 
with secondary antibodies (1:500 in blocking solution) for 1h at room temperature. Embryos 
were stained with DAPI (1:1000 dilution, in PBST, Life Technologies, D3571) for 15 min, 
followed by two washes in PBST. Primary antibodies: rabbit polyclonal anti-Pard6b (Santa 
Cruz, sc-67393, 1:200); anti ppMRLC2 (Cell Signalling, 3674P, 1:200), mouse monoclonal 
anti PKCζ (Santa Cruz, sc-17781, 1:50), rabbit polyclonal anti-CRB3 (Atlas antibodies, 
HPA013835, 1:50); mouse monoclonal anti-GFP (Nacalai Tesque Inc., 04404-84, 1:500); 
mouse monoclonal anti-Tfap2c (Santa Cruz, sc-12762, 1:200); rabbit monoclonal anti-Tead4 
(Abcam, ab97460, 1:200); rabbit monoclonal anti-Gata4 (Santa Cruz, sc-9053, 1:200); mouse 
monoclonal anti-Pou5f1 (Santa Cruz, sc-5729, 1:200); goat monoclonal anti Sox17 (R&D 
Systems, af1924); mouse monoclonal anti Cdx2 (Launch Diagnostics, MU392-UC 
(Biogenex)); rabbit monoclonal anti Nanog (Abcam, ab80892). Secondary antibodies: Alexa 
Fluor 568 Donkey anti-Goat (A-11057, ThermoFisher Scientific); Alexa Fluor 488 Donkey 
anti-Mouse, (A-21202, ThermoFisher Scientific); Alexa Fluor 568 Donkey anti-Mouse 
(A10037, ThermoFisher Scientific); Alexa Fluor 647 Donkey anti-Mouse (A31571, 
ThermoFisher Scientific); Alexa Fluor 568 Donkey anti-Rabbit (A10042, ThermoFisher 
Scientific); Alexa Fluor 647 Donkey anti-Rabbit (A-31573, ThermoFisher Scientific). 
 
2.8 RhoA-FRET imaging and data analysis 
The structure of RhoA FRET sensor Raichu-RhoA-CR was as described previously68. Raichu-
RhoA-CR, Clover mRNA and mRuby2 mRNA were injected into 2-cell stage embryos, and at 
the 4–8 cell stage, embryos were imaged under Leica TSC SP8 confocal microscope (Leica 
fluotar VISIR 0.95NA ×25 water objective). Images were acquired using the following 
excitation and emission settings: clover: 488 nm excitation, 505–540 nm emission; FRET: 
488 nm excitation, 580–650 nm emission; mRuby2: 568 nm excitation, 580–650 nm emission. 
Clover mRNA-injected embryos and mRuby2 mRNA-injected embryos were imaged first to 
determine the signal bleed-through (BT). Next, Raichu-RhoA-CR-expressing embryos were 
imaged with 20 min interval. For data analysis, the FRET and co-localisation analyser plugins 
in Fiji software were used to analyse the co-localisation between donor, FRET and acceptor 
channels to eliminate the noise generated by detectors. The radiometric image of FRET-co-
localisation and donor images were generated using the image calculation function in Fiji. Cell-
contact-free/cell-contact RhoA-FRET ratio is calculated by I cell-contact-free/I cell-contact. 
 
2.9 Optogenetics and regional PKC activation 
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2-cell stage embryos were injected with CIBN-Zsgreen-CAAX and CRY2-mCherry-PKC-KD 
or CRY2-mCherry-RhoA-Q63L-C190R or CRY2-mCherry and cultured in the dark. After 3 h, 
embryos were transferred to an optical glass bottom culture dish (MatTek Corporation) 
mounted with M2 medium and imaged under Leica TSC SP5 confocal microscopy (×63 oil 
objective). Laser power of 458 nm wavelength (8% for CRY2-mCherry-PKC-KD and CRY2-
mCherry, 4% for CRY2-mCherry-RhoA-Q63L-C190R) was used to illuminate a defined 
region in the cell-contact-free domain of the blastomeres using the region of interest tool in 
Leica Las AF software. The laser was illuminated for 5 s and followed with a 20 s interval. 
Each individual embryo was imaged for 15 min. 
 
 
2.10 Imaging and data processing 
Imaging was carried out on a Leica-SP5 or Leica-SP8 confocal using a Leica 1.4 NA 63X oil 
(HC PL APO) objective. Images were processed with Fiji software (35). For the analysis of 
nucleo-cytoplasmic signal intensity ratio, the region of the nucleus, and a cytoplasmic region 
of the same size, were cropped and the mean signal extracted using the Fiji ROI function. To 
normalise signals to the level of DAPI fluorescence, the Fiji ROI function was used to extract 
the nuclear region stained to reveal specific proteins and for the equivalent DAPI channel and 
normalisation performed using the formula: I(protein of interest)/ I (DAPI). For Ezrin apical 
enrichment analysis, a freehand line with the width of 0.5µm was drawn along the cell-contact 
free surface (apical domain), or cell-contact (basal) area of the cell, signal intensity were 
obtained via ROI function of Fiji. The apical/basal signal intensity ratio is calculated as: 
I(apical)/I(basal). Compaction was assessed by measuring the inter-cellular blastomere angle 
in the mid-plane between adjacent cells (as described previously (11)) by using the Fiji angle 
function.  
 
For live-imaging, time-lapse recordings of embryos were carried out using a spinning disk or 
a Leica-SP5 scanning confocal. For the blastomere resection experiment, time-lapse frames 
were acquired every 1h; for other live-imaging experiments, time-lapse frames were acquired 
every 20-30min. Images were acquired using a 3-4µm Z-step. Images were processed with Fiji 
software. Correlations were calculated using Prism software (http://www.graphpad.com). 
 
2.11 Real-time PCR 
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RNA was extracted from 8-cell stage embryos using the Arcturus PicoPure RNA isolation kit 
(Arcturus Bioscience). RT-PCR was performed using a StepOne Plus Real-time PCR machine 
(Applied Biosystem). The expression level was calculated using ddCT methods, normalised to 
a Gapdh PCR reaction and the endogenous control group. The primers used for RT-PCR are 
listed below: 
 
Table 2.4 Primers for real-time PCR 














Statistical methods are indicated for every experiment in the corresponding figure legends. 
Qualitative data is presented as a contingency table and was analysed using Fisher’s exact test. 
Normality of quantitative data was first analysed using D’Agostino’s K-squared test. A one-
sample t-test was used to test whether an observed distribution followed a hypothetical mean. 
If data showed a normal distribution, then for comparison of two or multiple samples, an 
unpaired two-tailed Student’s t test (two experimental groups) or a One-way ANOVA test 
(more than two experimental groups) was used to analyse statistical significance. Differences 
in variances were taken into account by performing a Welch’s correction. For data that did not 
present a normal distribution, a Mann–Whitney U-test (two experimental groups) or a Kruskal–
Wallis test with a Dunn’s multiple comparison test (more than two experimental groups) was 
used to test statistical significance. Statistical analyses were performed using Prism software 
(http://www.graphpad.com). 
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3 Results I: dissecting the molecular mechanism triggering cell 
polarity establishment – a requirement of the PLC-PKC 





Cell polarity establishment in the mouse embryo is a crucial event for the first cell fate 
specification. The apical domain, which is enriched by the Par complex (including aPKC and 
Pard6) and ERM protein family members, is necessary and sufficient for TE fate specification 
(Korotkevich et al., 2017). Despite the importance of the apical domain in developmental 
progression, how the apical domain first becomes established at the 8-cell stage, remains poorly 
understood. Work in other model systems points to a role of cytoskeleton dynamics in 
triggering de novo cell polarity establishment. However, the role of the cytoskeleton in apical 
domain formation is also under-investigation in the early mouse embryo. In this chapter, the 
dynamics of cytoskeletal networks, including actin and microtubules, and their contribution to 
apical domain establishment has been examined. This reveals that actomyosin reorganisation 
and polarisation is required for the formation of a matured apical domain. The upstream 
regulators controlling actin cytoskeleton reorganisation have been explored. Using a 
combination of pharmacological treatments, dominant negative constructs, as well as 
optogenetic activation, the PLC-PKC signalling pathway, and the downstream pathway 
regulating actomyosin apical polarisation and organisation has been defined.  
  
3.2 Actomyosin apical polarisation precedes apical domain maturation 
  
The maturation of apical domain is characterised by the apical enrichment of the Par complex, 
which consists of Pard6 and aPKC, localised in the centre of the cell-contact free surface, 
surrounded by an actin network which forms a "ring" like structure (Anani et al., 2014; Vinot 
et al., 2005) (Figure 3.1 A). The actomyosin network was recently found to be involved in de 
novo cell polarity establishment in several embryonic systems (Li and Gundersen, 2008; 
Schonegg and Hyman, 2006). To determine whether the actomyosin network plays an 
equivalent role in the apical domain assembly in the mouse embryo (Wedlich-Soldner et al., 
2003), the spatial-temporal dynamics of the actomyosin system in relation to apical domain 
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formation were examined at the 8-cell stage of development. To this end, early, mid, and late 
8-cell stage embryos were fixed according to the post-division hours (1-2 hrs for early 8-cell 
stage, 3-4 hours to mid-8-cell stage, and 5-9 hours to late 8-cell stage) and stained with 
filamentous actin (F-actin) as an actomyosin marker, and Pard6 as the matured apical domain 
marker. To precisely measure the 8-cell stage developmental progression, the inter-blastomere 
angle (the intracellular angle formed by adjacent blastomeres) was measured as a read out of 
compaction (Figure 3.1). This revealed that F-actin and Pard6b polarisation form a step-wise 
pattern:  during the early to mid 8-cell stage of development as the embryo compacts, F-actin 
became gradually polarised to the cell contact-free surface. Pard6b however, did not show any 
obvious asymmetry between cell contacts and cell contact-free surface during this stage (Figure 
3.2A-C). Only in the next couple of hours when the embryos compacted fully, did Pard6 begin 
to accumulate at the cell contact free surface. At the early phase of Pard6 apical accumulation, 
F-actin co-localised with Pard6b; yet at the later phase when the Pard6 apical signal increased, 
F-actin redistributed to the periphery of the Pard6 domain, suggesting a negative feedback 
mechanism between Pard6 and F-actin (Figure 3.2 A-D). 
 
 
Figure 3.1Measurement of inter-blastomere angle and the signal intensity.  (A) The angle 
between adjacent blastomeres were measured as a readout of compaction. The inter-blastomere 
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angle increases with cell compaction.  (B) A line with 0.8 µm was drawn across the cell contact-
free or cell contact region for signal intensity plotting. All scale bars, 15µm. 
 
 
Figure 3.2 Actomyosin and Pard6 dynamics during 8-cell stage development. (A) Embryos 
at the early, mid and late 8-cell stage were fixed and stained for F-actin and Pard6. Arrows 
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indicate the magnified cells on the right panel. The dash lines indicate the regions used in the 
signal plotting graphs in B. Colours of the dotted line correspond to the colours displayed as 
the background of the signal plotting graph in B.  (B) Plotting of the circumferential signal 
intensity of F-actin and Pard6b in cell contact and cell contact free region. Squares of different 
colours indicate cell contact (in yellow) and cell contact free surface (in blue) of plotted cells 
indicated in A. (C) Quantifications of F-actin and Pard6 normalised signal intensity in relation 
to inter-blastomere angle. Each dot indicates one analysed cell. The LOWESS curve was used 
to estimate the tendency, the shadows indicate a 95% confidence interval. (D) Summarised 
model of the two phases of cell polarity establishment. In the first phase, actomyosin is 
polarised to the cell contact-free surface, accompanied with cell compaction.  In the second 
phase, apical domain components are recruited to the cell contact-free surface and co-localise 
with actomyosin. Upon apical domain component enrichment, actomyosin is excluded from 
the centre and is reorganised into a ring domain. N = 25 embryos analysed, three independent 
experiments. All scale bars, 15µm. 
 
As an alternative readout for actomyosin localisation, the localisation of the myosin II complex 
was also examined. To this end, 2-cell stage embryos were injected with mRNA encoding a 
GFP tagged myosin light chain (GFP-MRLC) and fixed at the early, mid and late 8-cell stage 
with a post-division timing consistent with F-actin. Embryos were stained with anti-GFP (for 
GFP-MRLC) and Pard6. In agreement with the F-actin distribution pattern, GFP-MRLC also 
polarised apically during compaction and before Pard6 was polarised to the cell contact-free 
surface (Figure 3.3 A-C). Similar to F-actin, upon Pard6 apical accumulation, GFP-MRLC was 
re-distributed to the periphery of Pard6 domain (Figure 3.3 A-C). Together with the F-actin 
localisation pattern, these results suggest that the actomyosin complex polarises to the cell 
contact-free area prior to Par complex apical polarisation. 
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Figure 3.3 Dynamics of GFP-MRLC and Pard6 during the 8-cell stage of development. 
(A) The embryos expressing GFP-MRLC at the early, mid and late 8-cell stage were fixed and 
stained anti-GFP and Pard6. Arrows indicate the magnified cells on the right panel. The dotted 
lines indicate the regions used in the signal plotting graphs in B. Colours of the dotted line 
correspond to the colours displayed as the background of the signal plotting graph in B.  (B) 
plotting of the circumferential signal intensity of GFP-MRLC and Pard6b in cell contact and 
cell contact-free region. Squares of different colours indicate cell contact (in yellow) and cell 
contact-free surface (in blue) of plotted cells indicated in A. (C) Quantifications of GFP-MRLC 
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and Pard6 normalised signal intensity in relation to inter-blastomere angle. Each dot indicates 
one analysed cell. The LOWESS curve was used to estimate the tendency, the shadows indicate 
95% confidence interval. N=14 embryos, 4 independent experiments. 
 
The above results suggest that actomyosin polarises to the cell contact-free surface before 
Pard6b. To determine whether actomyosin polarisation is indeed the early cue for cellular 
asymmetry before the apical domain assembly, other apical domain components including 
aPKC, Ezrin, and Crb3 were also examined. For aPKC and Crb3, embryos were fixed at the 
same time-points as for Pard6b and immunostained with antibodies against aPKC zeta (aPKCζ) 
and Crb3. For Ezrin, mRNAs encoding a RFP tagged Ezrin (Ezrin-Ruby), and a GFP tagged 
actin-probe (LifeAct-eGFP) were injected at the 2-cell stage into both blastomeres. Embryos 
were filmed from the early 8-cell stage to the late 8-cell stage and the localisation of Ezrin-
Ruby and LifeAct-eGFP were recorded. Similar to Pard6b, aPKC, Ezrin and Crb3 only show 
apical localisation at the late 8-cell stage when F-actin or LifeAct were already polarised 
(Figure 3.4 A-D). 
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Figure 3.4 Dynamics of aPKC, Crb3 and Ezrin in relation to F-actin during the 8-cell 
stage development. (A)  Localisation pattern of F-actin and aPKC during the 8-cell stage 
development. Squares indicate the magnified region. Arrows indicate the apically localised 
aPKC. (B) Localisation pattern of F-actin and Crb3 during the 8-cell stage development. 
Squares indicate the magnified region. Arrows indicate the apically localised Crb3. (C) 
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Snapshots of time-lapse recordings of embryos expressing Ezrin-Ruby and LifeAct-eGFP. 
Arrows indicate the polarised localisation of LifeAct-eGFP or Ezrin-Ruby. (D) Quantification 
of Ezrin and LifeAct-eGFP cell contact-free enrichment. Quantifications were fitted into a 
"Boltzmann sigmoidal" model based curve (R2= 0.8886 for Ezrin-Ruby, R2=0.5198 for 
LifeAct-eGFP). N=10 embryos, 3 independent experiments. All scale bars, 15µm. 
 
 
Taken together, these results indicate that during the 8-cell stage development, as the embryo 
compact, actomyosin polarises to the cell contact-free surface, and this precedes apical domain 
establishment. Thus actomyosin is likely to be among the earliest molecules that is associated 
with symmetry breaking events coordinating cell polarity establishment in the 8-cell stage 
mouse embryo.  
  
  
3.3 Actomyosin apical polarisation is required for Par complex enriched apical 
domain assembly  
 
3.3.1 Pharmacological perturbation of the actomyosin structure from the early 8-cell 
stage inhibits compaction and apical domain assembly 
The above results suggest that actomyosin accumulates to the cell contact-free surface before 
the maturation of the apical domain, indicating a role for actomyosin asymmetry in assembling 
the matured apical domain. To functionally test this hypothesis, different strategies to down-
regulate the actomyosin complex were employed. In the first attempt, the siRNA targeting 
Myl12b, the highest expressed myosin light chain isoform, was injected into the zygote to 
prevent myosin II formation. However, this RNAi strategy was unsuccessful as although the 
siRNA effectively eliminated Myl12b (by 74%, Figure 3.5A), no significant down-regulation 
of the myosin light chain protein was observed. This indicates that the presence and function 
of the protein of the myosin II complex at the 8-cell stage is regulated by the maternal store 
(Figure 3.5B). 
 




Figure 3.5 The RNAi method failed to effectively eliminate Myl12b protein due to the 
maternal store. (A) Verification of the efficiency of Myl12b siRNA by qPCR. Data are shown 
as mean ± S.E.M. N=1 experiments. N=20 embryos per each group. (B) Embryos injected with 
Control siRNA or Myl12b siRNA were fixed at the late 8-cell stage and stained for ppMRLC. 
N=8 embryos for DMSO and N=9 embryos for Blebbistatin, 2 independent experiments. All 
scale bars, 15µm. 
 
Next, pharmacological inhibition methods were used to block actomyosin activity. Actomyosin 
activation starts by myosin light chain phosphorylation, which triggers the packing of the 
myosin light chain and heavy chain, resulting in myosin II filament assembly. The myosin II 
filament, once formed, is able to bind to the polymerised actin network and starts contracting, 
through constant cycling between ADP to ATP. Two myosin II inhibitors, namely Blebbistatin 
and ML-7 were used to block myosin II ATPase activity (Blebbistatin) thus contractility, or to 
block the phosphorylation of the myosin light chain (ML-7), which antagonises myosin light 
chain kinase (MLCK) activity thus blocking the myosin II filament formation. The inhibitors 
were added from the early 8-cell stage (to eliminate the effects on cytokinesis) and the embryos 
were fixed at the late 8-cell stage (Figure 3.6A-D). The localisation of Pard6 and F-actin was 
subsequently examined. The intra-blastomere angle (IEA) was measured as a readout of 
compaction. Consistent with the previous study, Blebbistatin treatment effectively blocked cell 
compaction (Maitre et al., 2015), as the IEA remained at a similar level to that of the early 8-
cell stage (Figure 3.6A-B). Surprisingly, both Pard6b and F-actin still effectively polarised to 
the cell contact-free surface and eventually formed the apical cap structure (Figure 3.6 A-D). 
This phenotype was independent of the timing of treatment or the concentration of the drug, as 
when Blebbistatin concentration was increased to 50uM, or the treatment was administered at 
the late 4-cell stage, a similar phenotype was observed (Figure 3.5E). This indicates that 
although actomyosin contractility is required for cell compaction, it is not essential for apical 
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domain establishment. This result also suggests that cell compaction is not required for the 
formation of the apical domain, but rather they are parallel events. In contrast, ML-7 treatment 
not only blocked cell compaction (Figure 3.6 A-D), but also abolished the apical recruitment 
of both Pard6 and F-actin (Figure 3.6 A-D). Particularly, F-actin organisation appeared largely 
disorganised upon ML-7 treatment. In the DMSO treated control embryos, at the late 8-cell 
stage actin formed dense filaments on the outside of the actomyosin ring structure and a puncta-
like lattice network on the inside of the ring. In ML-7 treated embryos the actin cortex density 
was significantly reduced, and isotropic and dispersed actin patches were observed on the 
surface of each blastomere (Figure 3.6A), indicating that lack of myosin II filaments 
significantly affected the organisation of actin.  To unequivocally determine the effectiveness 
of ML-7, embryos treated with DMSO or ML-7 were fixed at the late 8-cell stage and stained 
for di-phosphorylated myosin light chain (ppMRLC). In the DMSO treated late 8-cell stage 
embryos, ppMRLC was polarised to the cell contact-free surface, in agreement with the F-actin 
and GFP-MRLC staining. In ML-7 treated embryos however, ppMRLC apical accumulation 
was largely reduced (Figure 3.6 F-G). On the contrary, Blebbistatin treatment did not affect the 
level of ppMRLC (Figure 3.6 H-I). These results suggest that actomyosin activation, rather 
than contractility, is required for apical domain assembly.  
 
As an alternative way to destroy the actomyosin network, Lat-B, a potent antibiotic which 
induces actin depolymerisation, was administered from the early 8-cell stage to the late 8-cell 
stage and polarisation. Embryos were then fixed and stained for F-actin and Pard6b, as earlier 
described.  Consistent with the ML-7 treatment, Lat-B treatment strongly decreased the density 
of F-actin, and inhibited compaction (Figure 3.6A-C). More importantly, Pard6 failed to 








Figure 3.6 The effects of different actomyosin inhibitors on polarisation revealed that 
actomyosin activation but not contractility is required for apical domain assembly. (A) 
The embryos treated with Blebbistatin, ML-7 and Lat-B were fixed at the late 8-cell stage and 
stained for Pard6 and F-actin. (B, C) Quantification of inter-blastomere angle, F-actin and 
Pard6 apical enrichment in embryos treated with DMSO, Blebbistatin, ML-7 and LatB. Each 
dot indicates a measured cell. The measurements of cells in the same treatment group were 
indicated using a circle. Number of embryos per each condition is indicated in (D). N=3 
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experiments. (D) Quantification of polarisation rate in DMSO, Blebbistatin, ML-7 and Lat-B 
treatment. Numbers in each bar represent the number of analysed cells showing a 
polarised/unpolarised phenotype. ****p < 0.0001, NS = not significantly different, Fisher’s 
exact test. (E) Embryos treated with Blebbistatin at different stages or different concentrations 
were fixed at the late 8-cell stage and stained for F-actin and Pard6. (F) Embryos treated with 
DMSO (as a control) or ML-7 were fixed at the late 8-cell stage and stained for ppMRLC. (G) 
Quantification of ppMRLC apical enrichment in DMSO or ML-7 treated cells. Data are shown 
as individual data points with a Box and Whiskers graph (bottom: 25%; top: 75%; line: median; 
whiskers: min to max). Each dot represents an analysed cell. N = 10 embryos for DMSO and 
N = 12 embryos for ML-7, 4 independent experiments. ****p < 0.0001, Mann–Whitney test.  
(H) Embryos treated with DMSO or Blebbistatin were fixed at the late 8-cell stage and stained 
for ppMRLC. (I) Quantification of ppMRLC apical enrichment in DMSO or Blebbistatin 
treated cells. Data are shown as individual data points with Box and Whiskers graph (bottom: 
25%; top: 75%; line: median; whiskers: min to max). Each dot represents an analysed cell. ns, 
not significant, Mann–Whitney test. N=8 embryos for DMSO and N=9 embryos for 
Blebbistatin, 2 independent experiments All scale bars, 15µm. 
 
Taken together, various pharmacological methods to destroy actomyosin architecture suggest 
that the early asymmetry of actomyosin complex to the cell-contact free surface primes the 
apical accumulation of various apical domain proteins to form the matured apical domain.  
 
 
3.3.2 ML-7 treatment from the mid 8-cell stage inhibits specifically apical domain 
assembly 
To unequivocally determine whether the intact actomyosin architecture is required for apical 
domain assembly, as opposed to it being a secondary result of the failure of compaction, ML-
7 was applied at the mid 8-cell stage when the embryos had already compacted. At the late 8-
cell stage (4 hours after the drug application) embryos were fixed and stained for F-actin and 
Pard6. It was observed that this treatment allowed the embryos to remain compacted (Fig 7). 
However, F-actin and myosin apical polarisation was strongly impaired, and Pard6b still failed 
to polarise to the apical domain (Figure 3.7).   




Figure 3.7 ML-7 treatment from the mid 8-cell stage after compaction abolished apical 
domain establishment. (A) Embryos treated with DMSO or ML-7 were fixed at the late 8-
cell stage and stained for F-actin, GFP-MRLC and Pard6b. Squares indicate the magnified 
region. (B) Quantification of the contact angles in the cells treated with DMSO and ML-7. ns, 
not significant; unpaired student’s t-test. (C) Quantification of the GFP-MRLC cell-contact 
free surface enrichment in cells treated with DMSO or ML-7. ****p<0.0001; unpaired 
student’s t-test. (D) Quantification of the GFP-MRLC cell-contact free surface enrichment in 
cells treated with DMSO or ML-7. ****p<0.0001; unpaired student’s t-test. N=9 embryos for 
DMSO and N=10 embryos for ML-7, 4 independent experiments. All scale bars, 15µm. 
 
Combined with the results from section 3.3.1, these results strongly suggest that actomyosin 
apical polarisation is required for the subsequent apical domain establishment, and it this is 
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3.3.3 Myosin light chain phosphorylation starts from the early 8-cell stage 
As compaction and polarisation events are conserved processes among different mammalian 
species, the understanding of the timing mechanism of compaction and polarisation is another 
interesting and fundamental topic in mammalian embryo development. Based on the 
observation that actomyosin activity is bound to compaction and polarisation, it is highly likely 
that the dynamic changes of activated actomyosin are associated with temporal events, thus it 
is important to dissect the timing of actomyosin activation and polarisation. To this end, early, 
mid and late 4-cell stage as well as early, mid and late 8-cell stage embryos were fixed and 
stained for ppMRLC. This reveals, that actomyosin activation happens in a stage-dependent 
manner. The level of cortical ppMRLC remains low or undetectable throughout 4-cell stage 
development. However, from the early 8-cell stage, ppMRLC can be detected initially in the 
cortex region all around the cell (early 8-cell stage), and then gradually at the cell contact-free 
surface until the late 8-cell stage (Figure 3.8A-).This is in agreement with the localisation 




Figure 3.8 ppMRLC levels are upregulated from the early 8-cell stage. (A) The embryos 
of early, mid and late 8-cell stage are fixed and stained for ppMRLC. The stars indicate the 
apical domain, the yellow arrows indicate the ppMRLC enrichment. Pink squares indicate the 
magnified region. (B) Quantification of ppMRLC level at different developmental stages at 
cell-contact or cell-contact free surface. N = 32 measurements from 7 late 4-cell stage embryos; 
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N = 69 measurements from 11 early 8-cell stage embryos; N = 86 measurements from 11 mid 
8-cell stage embryos; N = 50 measurements from 13 late 8-cell stage. 3 independent 
experiments. All scale bars, 15µm. 
  
Taken that ppMRLC is a bona fide marker for actomyosin activation, these results suggest that 
the actomyosin network is specifically activated only around the early 8-cell stage, concomitant 
with the timing of compaction and the establishment of the apical domain.   
  
 
3.4 The PLC-PKC pathway is required for apical domain assembly 
  
3.4.1 PKC is required not only for cell compaction but also for apical domain 
establishment 
The PKC protein family consists of 3 sub-families: conventional PKCs, novel PKCs and 
atypical PKCs. The different sub-families are activated by unique and specific mechanisms. 
Activation of Conventional PKCs requires production of the second messenger diacyl-glycerol 
(DAG) and an increase in intracellular calcium levels. Activation of Novel PKCs requires DAG 
but not calcium. Atypical PKCs, as previously described, are the major kinases of the Par apical 
polarity complex, and they are activated independently of DAG and calcium. Since the PKC 
activators PMA, diC8, TPA and OAG, which trigger pre-mature compaction, are the analogue 
of DAG, the activation of conventional or novel PKCs may be involved in the compaction 
event.  
The classical signalling pathway that activates conventional and novel PKCs is Phospholipase 
C (PLC)-induced Phosphatidylinositol 4,5-bisphosphate (PIP2) cleavage. PIP2 is a minor 
phospholipid present in cell membranes, which participates in multiple signalling transduction 
pathways. Upon stimulation, activated PLC will cleave PIP2 to generate DAG and Inositol 
1,4,5-triphosphate (IP3). The latter activates calcium channels situated in the endoplasmic 
reticulum leading to an elevation of cytoplasmic calcium levels. The elevated calcium levels, 
together with DAG, induce PKC activation (Figure 3.9). 
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Figure 3.9 Schematic view of PLC-PKC pathway. The activation of PLC by multiple 
different upstream signalings triggered the hydrolysis of PIP2 into DAG and IP3. DAG directly 
activate PKC activation and IP3 first activated the ER membrane bound Calcium channel to 
induce a cytoplasmic calcium wave, which in turn activate PKC. As a results, DAG and IP3 
both are able to induce PKC activation.  
 
As the actomyosin system is specifically activated at the 8-cell stage, the identification of the 
upstream actomyosin activator is critical for understanding the timing of compaction and apical 
domain establishment as well as the regulatory mechanism behind both of these events. PKC 
activity has been implicated in triggering compaction, however its potential requirement for 
actomyosin activation and relationship to cell polarisation unclear.  To investigate whether 
PKC activity is required for polarisation two selective PKC inhibitors, sphingosine and 
calphostin C, which specifically inhibit conventional and novel PKC but not the cell polarity-
related protein atypical PKC, were applied at the late 4-cell stage (Figure 3.10 A). Embryos 
were fixed at the late 8-cell stage and stained for F-actin and Pard6b. Both sphingosine and 
calphostin C effectively blocked cell compaction at the late 8-cell stage (Figure 3.10 B-D), 
consistent with the earlier studies suggesting that PKC is required for cell compaction(Winkel 
et al., 1990). More importantly, F-actin and Pard6 also failed to polarise to the cell contact-free 
surface (Figure 3.10 B-D), suggesting that PKC is important for the apical domain 
establishment.  
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Figure 3.10 PKC inhibitors abolished cell compaction and polarity establishment. (A) 
Scheme of inhibitor treatment. Two PKC inhibitors that specifically inhibit canonical and novel 
PKC, but not atypical PKC were added to the medium from the 4-cell stage until the late 8-cell 
stage. (B) Embryos treated with DMSO (as a control), Sphingosine and Calphostin C were 
fixed at the late 8-cell stage and stained for F-actin and Pard6. (C, D) Quantification of inter-
blastomere angle, F-actin and Pard6 apical enrichment in embryos treated with DMSO, 
Sphingosine and Calphostin C. Each dot indicates an analysed cell. The measurements of cells 
in the same treatment group were indicated using a circle. Number of embryos analysed for 
each condition has been indicated in (E). N=3 independent experiments. (E) Quantification of 
the percentage of embryos that show polarised cells under DMSO, Sphingosine and Calphostin 
C treatments.  Data are shown as a contingency table, the number in each bar indicates the 
number of embryos analysed. ****p<0.0001, Fisher’s exact test. (F) Quantification of 
polarised cell number in embryos treated with DMSO, Sphingosine and Calphostin C. Data are 
shown as mean ± S.D. All scale bars, 15µm. 
 
3.4.2 PLC activation lies upstream of PKC and is required for apical domain assembly 
and the subsequent TE specification events 
Conventional and novel PKC activation is triggered by the generation of two second 
messengers, DAG and IP3, from a membrane phospholipid PIP2, and catalysed by the enzyme 
Phospholipase C (PLC). As an alternative to PKC inhibition, the activity of PLC was blocked 
by treatment with the selective pan-PLC inhibitor, U73122 (Figure 3.11A). The embryos were 
fixed at the late 8-cell stage and their polarisation status was examined. The immunostaining 
of F-actin and Pard6 revealed that, U73122 treatment blocked cell polarisation at the late 8-
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cell stage (Figure 3.11 B-G). To determine whether these phenotypes resulted from the 
inactivation of PKC, a rescue experiment was performed. Specifically, the PKC activator OAG 
(analogue of DAG), was added from the early 8-cell stage and embryos were fixed at the late 
8-cell stage and stained for F-actin and Pard6. The examination of compaction and F-actin and 
pard6 localisation revealed that, the re-activation of PKC can effectively rescue compaction 
and polarisation defects caused by PLC inhibition (Figure 3.11 B-G), suggesting that the 
phenotype observed from PLC inhibition was indeed due to PKC inactivation. The effect from 
U73122 was not likely due to the impaired cell fitness as the washout of U73122 allowed the 
embryos to develop to blastocyst stage (data not shown).  
 
The cell polarity defects were long-lasting in the U-73122 treated embryos, as the cells were 
unable to polarise at the 16-cell stage and the subsequent cell differentiation events, such as 
the induction of Cdx2, were abolished. This suggests that apical domain assembly was indeed 
suppressed by the inhibition of PLC.  
 
Inhibitors can very often cause off-target effects and so, to further determine whether the 
phenotype observed from U73122 treatment were specifically due to PLC inactivation, other 
methods of PLC inhibition were explored. To this end, a dominant negative form of PLC (PH 
domain of Plcd1, referred as PLC-DN) were constructed and overexpressed at the 2-cell stage 
(Figure 3.12A). To visualise PLC-DN localisation, Ruby (a modified form of RFP) was tagged 
to the C-terminal of PLC-DN. Ruby mRNA overexpression alone has been used as the control 
condition.  The embryos were fixed at the late 8-cell stage and the degree of cell compaction 
and cell polarisation was analysed. Consistent with pharmacological treatment experiments, 
PLC-DN effectively blocked cell compaction, as well as the apical polarisation of F-actin and 
Pard6b (Figure 3.12B-F). Consistent with the U73122 experiment, the defects in cell polarity 
were effectively rescued by OAG treatment from the early 8-cell stage, indicating that the 
polarity phenotype caused by PLC-DN overexpression was due to the downregulation of PKC 
activity. Beyond the 8-cell stage, the embryos overexpressing PLC-DN still failed to polarise, 
and the downstream TE specification was abolished (Figure 3.11G-H), indicating that apical 
domain function was completely blocked by the inhibition of PLC activity. 
  
Combined, these results consistently show that PKC activation, triggered by PLC activity, is 
required not only for cell compaction, but also for the establishment of the apical domain.  
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Figure 3.10 Inhibition of PLC activity abolished compaction, cell polarisation and 
subsequent TE specification events upstream of PKC signalling. (A) Scheme of PLC 
inhibitor treatments. Selective pan-PLC inhibitor U73122 was treated from late 4-cell stage, 
for OAG rescue group, the OAG was added at the presence of U73122 at the early 8-cell stage. 
(B) Embryos treated with DMSO (control), U73122 or U73122+OAG were fixed at the late 8-
cell stage and stained for F-actin and Pard6. (C) Time-lapse movie of embryos treated with 
DMSO or U73122 from 4-8 cell stage to 8-16 cell stage. (N=72 embryos for DMSO and N=127 
embryos for U73122, 12 independent experiments). (D, E) Quantification of inter-blastomere 
angle, F-actin and Pard6 apical enrichment in embryos treated with DMSO, U73122 and 
U73122+OAG group. Each dot indicates an analysed cell. The measurements of cells in the 
same treatment group were indicated using a circle. Number of embryos analysed were 
indicated in (F). (F) Quantification of the percentage of embryos that show polarised cells 
under DMSO, U73122 and U73122+OAG treatments.  Data are shown as a contingency table, 
the number in each bar indicates the number of embryos analysed. N=2 independent 
experiments. ns, not significant; ****p<0.0001, Fisher’s exact test. (F) Quantification of 
polarised cell number in embryos treated with DMSO, Sphingosine and Calphostin C. Data are 
shown as mean ± S.D. ns, not significant; ***p<0.01; ****p<0.0001; Kruskal–Wallis test and 
Dunn’s multiple comparisons test. 64 embryos for DMSO group; 23 embryos for Sphingosine 
group; 51 embryos for Calphostin C group. N=3 independent experiments. (H) Embryos 
treated with DMSO or U73122 were fixed at the 16-cell stage embryos and stained for F-actin 
and Pard6. (N=18 embryos for DMSO and N=16 embryos for U73122, 3 independent 
experiments). (I) Quantifications of the total cell numbers in embryos treated with DMSO or 
U73122. Data are shown as mean ± S.D. *p<0.05, Student’s t-test. (J) Embryos treated with 
DMSO or U73122 were fixed at the 16-cell stage and stained for Pard6 and Cdx2. (N=10 
embryos for each group; N=1 experiment). (K) Quantifications of the percentage of Cdx2 
positive cells in embryos treated with DMSO or U73122 at the 16-cell stage. ****p<0.0001, 
Fisher’s exact test. All scale bars, 15µm. 
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Figure 3.11 Overexpression of PLC-DN abolished cell compaction, polarity establishment 
and TE specification. (A) Scheme of PLC-DN overexpression. (B) Embryos overexpressing 
Ruby (control) and PLC-DN were fixed at the late 8-cell stage and stained for F-actin and 
Pard6. (C) Quantification of the percentage of embryos that showed polarised cells in Ruby or 
PLC-DN overexpression conditions.  Data are shown as a contingency table, the numbers in 
each bar indicate the number of embryos analysed. ** p<0.01, ****p<0.0001, Fisher’s exact 
test. N=2 independent experiments. (D) Quantification of polarised cell number in embryos 
overexpressing Ruby or PLC-DN. Data are shown as mean ± S.D. ns, not significant; *p<0.05; 
**p<0.01; Kruskal–Wallis test and Dunn’s multiple comparisons test. Number of embryos 
analysed were indicated in (C). (E) Time-lapse movie of embryos expressing Ruby or PLC-
DN from 4-8 cell stage to 8-16 cell stage of development. (F) Quantification of the total cell 
number in embryos expressing Ruby or PLC-DN. Data are shown as mean ± S.D. ns, not 
significant; Student’s t-test. (G) Embryos expressing Ruby or PLC-DN were fixed at the 16-
cell stage and stained for Pard6 and Cdx2. (H) Quantification of the percentage of cells 
expressing Cdx2. ****p<0.0001, Fisher’s exact test. (N=8 embryos for each group, 4 
independent experiments). All scale bars, 15µm. 
 
3.5 PLC-PKC activity is necessary and sufficient for actomyosin asymmetry 
during the 8-cell stage development 
  
3.5.1 PKC is required for the apical polarisation of the activated actomyosin meshwork 
As the results above suggest that both actomyosin polarisation and PKC activation are required 
for compaction as well as the establishment of the apical domain, it is conceivable that PKC 
controls compaction and apical domain establishment through the regulation of actomyosin. 
To test this possibility, PLC or PKC activity were inhibited with the use of methods described 
in the above sections (calphostin C, sphingosine treatment for PKC inhibition; U-73122 
treatment and PLC-DN overexpression for PLC inhibition). For all conditions, embryos were 
fixed at the late 8-cell stage and stained for ppMRLC and F-actin. While at the late 8-cell stage 
control embryos (DMSO treatment or Ruby injected embryos), ppMRLC were strongly 
enriched in the cell contact-free cortex, co-localising with F-actin (Figure 3.13A-H), all 
methods of PLC or PKC inhibition consistently led to dramatic down-regulation of the apical 
ppMRLC enrichment (Figure 3.13A-H).  
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These results suggest that, as expected the PLC-PKC pathway is required for the apical 
enrichment of the activated actomyosin network, and thus compaction and apical polarisation.  
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Figure 3.12 PKC activity is required for actomyosin activation and polarisation. (A) 
Embryos treated with DMSO or Sphingosine were fixed at the late 8-cell stage and stained for 
ppMRLC and F-actin. (B) Quantification of ppMRLC apical enrichment in the cells treated 
with DMSO or Sphingosine. N = 9–10 embryos, 2 independent experiments. (C) Embryos 
treated with DMSO or Calphostin C were fixed at the late 8-cell stage and stained for ppMRLC 
and F-actin. N = 11 embryos for DMSO and N = 9 embryos for Calphostin C, 2 independent 
experiments. (D) Quantification of ppMRLC apical enrichment in the cells treated with DMSO 
or Calphostin C. (E) Embryos treated with DMSO or U73122 were fixed at the late 8-cell stage 
and stained for ppMRLC and F-actin. (F) Quantification of ppMRLC apical enrichment in the 
cells treated with DMSO or U73122. N = 20 embryos for DMSO and N = 22 embryos for 
U73122, three independent experiments. (G) Embryos overexpressing Ruby or PLC-DN were 
fixed at the late 8-cell stage and stained for ppMRLC and F-actin.  (H) Quantification of 
ppMRLC apical enrichment in the cells overexpressing Ruby or PLC-DN. Arrowheads indicate 
apically localised ppMRLC and squares indicate the magnified regions. N = 7 embryos for 
Ruby and N = 8 embryos for PLC-DN, 2 independent experiments. All data are shown as 
individual data points with Box and Whiskers graph (bottom: 25%; top: 75%; line: median; 
whiskers: min to max). ****p<0.0001, Mann–Whitney test. All scale bars, 15 µm. 
 
3.5.2 Ectopic PKC activation is sufficient to polarise actomyosin at the 4-cell stage 
To test the effect of ectopic PKC activation on cell polarity establishment, OAG was applied 
at the early 8-cell stage. The embryos were then fixed at the late 8-cell stage or 16-cell stage 
and stained for F-actin and Pard6. This revealed that, upon PKC activation, the Par complex 
enriched apical domain was expanded. In the DMSO treated control embryos, the Par complex 
occupied a proportion of the cell contact-free surface (mean surface coverage ratio (SCR) of 
57.3%; Figure 3.14A-C). OAG treatment expanded the apical domain to the whole cell contact-
free surface (mean SCR 84.8%; Figure 3.14A-C).  As a result of OAG of treatment, Pard6 
localisation expanded to the cell contacts (Figure 3.14D-E).  




Figure 3.13 Ectopic activation at early 8-cell stage led to the expansion of apical domain. 
(A) Embryos treated with DMSO or OAG were fixed at the 8-cell stage and stained for F-actin 
and Pard6. Squares indicate the magnified region. White arrows indicate the apical domain, 
yellow arrows indicate the cell-contact free surface. (B) Quantification of the coverage of the 
apical domain in DMSO or OAG treated cells. Data are shown as individual data points with 
Box and Whiskers graph (bottom: 25%; top: 75%; line: median; whiskers: min to max). 
****p < 0.0001, two-tailed unpaired Student’s t test. (C) Quantification of inter-blastomere 
angle, F-actin and Pard6 apical enrichment in embryos treated with DMSO and OAG group. 
Each dot indicates an analysed cell. Cells in the same treatment group were indicated using a 
circle. For both B and C, N = 8 embryos for DMSO and N = 6 embryos for OAG, 4 independent 
experiments. (D) Embryos treated with DMSO or OAG were fixed at the 16-cell stage and 
stained for F-actin and Pard6. (E) Quantification of Pard6 cell contact enrichment in the outer 
cells of embryos treated with DMSO or OAG. Data are shown as Box and Whiskers graph 
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(bottom: 25%; top: 75%; line: median; whiskers: min to max). ***p<0.001, Mann–Whitney 
test. All scale bars, 15 µm. 
 
To determine whether PKC activation is able to trigger the premature activation of the apical 
domain, two different approaches were taken for PKC activation: A constitutively activated 
form of PKC-alpha (Prkca-A25E) and the PKC activator OAG were used.  OAG was added at 
the early 4-cell stage, and the embryos were fixed after 4 hours induction and stained for F-
actin, ppMRLC and Pard6. Consistent with earlier reports, OAG treatment prompted the 
embryo to prematurely compact within 30 minutes (Winkel et al., 1990) (Figure 3.15A). In the 
meantime, F-actin and ppMRLC polarised to the cell contact-free surface upon OAG treatment 
(Figure 3.15A-B). Although Pard6b was slightly enriched at the cell contact-free surface 
(Figure 3.15A,C), the level of enrichment was much lower than at the apical domain of a natural 
8-cell stage embryo, suggesting that no mature apical domain was successfully induced.  
 
mRNA encoding PKCɑ-A25E was injected into 2 blastomeres at the early 4-cell stage, while 
mRNA encoding GFP-MRLC was co-injected to visualise actomyosin localisation. The 
embryos were fixed at the late 4-cell stage and stained for anti-GFP (for GFP-MRLC), F-actin 
and Pard6b (Figure 3.15D).  mRNA of GFP-MRLC alone was injected as a control. At the late 
4-cell stage, while GFP-MRLC alone showed homogeneous distribution among the cell 
membranes (Figure 3.14D), the co-overexpression of PKCalpha-A25E induced GFP-MRLC 
to polarise to the cell contact-free surface (Figure 3.15D-E). Consistently, F-actin also 
polarised toward the cell contact-free surface (Figure 3.15D,F). Although both GFP-MRLC 
and F-actin polarised to the cell contact-free surface, Pard6 remained unpolarised in all of the 
embryos examined, consistent with the results of OAG treatment (Figure 3.15G). These results 
indicate that although PKCalpha-A25E is sufficient to polarise the actomyosin complex 
prematurely at the 4-cell stage, other factors are required to polarise the Par complex and thus 
drive apical domain maturation. 
 
Together, PKCɑ-A25E overexpression and OAG treatment experiments suggest that PKC 
ectopic activation is sufficient to induce actomyosin asymmetry but other factors are required 
to establish a matured apical domain.  
 




Figure 3.14 PKC activation at the 4-cell stage induces actomyosin polarisation but not 
apical domain formation.  (A) Embryos treated with DMSO or OAG were fixed at the late 4-
cell stage and stained for F-actin, ppMRLC and Pard6. Arrows indicate the polarised 
actomyosin complex. (B) Quantification of apical ppMRLC enrichment in the cells treated with 
DMSO or OAG at the 4-cell stage. ****p < 0.0001; Mann–Whitney test. (C) Quantification of 
apical Pard6 enrichment in the cells treated with DMSO or OAG at the 4-cell stage. ns, not 
significant; Mann–Whitney test. For both B and C, N=18 embryos for DMSO; N=10 embryos 
for OAG. 6 independent experiments. (D) mRNA encoding GFP-MRLC with or without 
PKCɑ-A25E were fixed at the late 4-cell stage and stained for GFP, F-actin and Pard6. Arrows 
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indicate an injected cell. (E) Quantification of GFP-MRLC apical enrichment in cells 
expressing GFP-MRLC with or without PKCɑ-A25E. **p<0.01; Mann–Whitney test. (F) 
Quantification of F-actin apical enrichment in cells expressing GFP-MRLC with or without 
PKCɑ-A25E. ****p<0.0001; Mann–Whitney test. (G) Quantification of Pard6 apical 
enrichment in cells expressing GFP-MRLC with or without PKCɑ-A25E. ns, not significant; 
Mann–Whitney test. For both F and G, N = 6 embryos, three independent experiments. All data 
are shown as individual data points with Box and Whiskers graph (bottom: 25%; top: 75%; 
line: median; whiskers: min to max). All scale bars, 15 µm. 
 
  
3.5.3 PKC directly activates actomyosin  
As the above results demonstrated that PKC is sufficient to polarise the actomyosin complex, 
the mechanism driving this process was investigated further. Two potential models were 
hypothesised to explain how PKC can trigger actomyosin polarisation: 1) actomyosin is 
activated by other factors, and PKC may help to stabilise cell contacts and therefore restrict the 
activated actomyosin complex specifically to the cell contact-free domain; 2) PKC directly 
activates actomyosin and the already established cell contacts help to polarise actomyosin.  
 
To specifically test these two models, a recently developed optogenetic approach was adapted 
to the mouse embryo and used to activate PKC at the precise region of interest. Specifically, 
the CRY2-CIB1 system was used. The CRY2-CIB1 system constitutes of two domains, CRY2 
and CIB1, the binding which is triggered by blue light excitation. In the absence of blue light 
input, the binding is automatically reversed within a defined time frame. To activate PKC at a 
defined cortical region, a CAAX motif was linked to CIB1 domain in order to constitutively 
localise this domain to the membrane (CIB1-CAAX); the kinase domain of PKCɑ was fused 
to the CRY2 domain (CRY2-PKC-KD) (Figure 3.16A). As expected, without blue light CRY2-
PKC localised in the cytoplasm and CIB1-CAAX on the membrane (Figure 3.16B). 488nm 
blue light activation triggered the membrane recruitment of CRY2-PKC-KD within 10 minutes 
(Figure 3.16B). The embryos were fixed after 30 minutes of activation and stained for F-actin, 
ppMRLC and Pard6b. An upregulation of ppMRLC and F-actin (Figure 3.16C) was observed 
specifically in the region of CRY2-PKC-KD recruitment to the membrane, indicating that 
PKC-KD membrane recruitment results in the local activation of the actomyosin complex. To 
validate whether the upregulation of actomyosin activity was indeed due to PKC but not as a 
result of artefacts caused by the imaging of the optogenetic constructs, the CIB1-CAAX and 
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CRY2 domain were co-expressed and the embryos were imaged using the same conditions as 
for CRY2-PKC-KD. The CRY2 domain was effectively recruited to the membrane as CRY2-
PKC-KD (Figure 3.16D), yet no upregulation of ppMRLC was observed (Figure 3.16E).  
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Figure 3.15 Regional PKC activation induces local actomyosin activation. (A) Scheme of 
the optogenetic methods for PKC activation. (B) Snapshots of PKC-KD localisation upon 
the introduction of blue light, arrows indicate the membrane enrichment of PKC-KD. Image 
represents N=24 embryos from N=11 independent experiments. (C) Cells expressing CIB1-
CAAX and CRY2-PKC-KD were illuminated with blue light and fixed and stained for F-actin, 
ppMRLC and Pard6. Arrows indicate the illumination site. (D) Cells expressing CIB1-CAAX 
and CRY2-mCherry were fixed and stained for ppMRLC. (E) Quantifications of ppMRLC 
cortical enrichment of cells illuminated or not illuminated with blue light, expressing various 
combinations of optogenetic constructs. ns, not significant; *p<0.05; **p<0.01; Mann-
Whitney test. (N=17 embryos for PKC-KD activated region, N=9 embryos for PKC-KD non-
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activated region, N=7 embryos for RhoA-Q63L-C190R activated region, N=13 embryos for 
RhoA-Q63L- C190R non-activated region and N=10 embryos for mCherry only, 3 
independent experiments for mCherry only, 2 independent experiments for all the other 
conditions). All scale bars, 15µm. 
 
 
3.6 Rho-GTPases lie downstream of PKC and establish the apical domain 
  
3.6.1 A myosin light chain phosphorylation independent mechanism is involved in PKC 
mediated actomyosin activation 
Since PKC inhibition led to the loss of cortical MRLC accumulation (Figure 3.13), it was 
hypothesised that PKC may activate actomyosin through triggering MRLC filament assembly 
by promoting MRLC phosphorylation, or through assisting the actomyosin filaments to 
localise to the cortex. To test these hypotheses, a phosphomimetic form of MRLC (MRLC-DD) 
was constructed. In other systems, the overexpression of this phosphomimetic form was able 
to bypass the phosphorylation step and trigger myosin II filament formation (Vicente-
Manzanares and Horwitz, 2010). To test the efficacy of this construct, the mRNA of GFP-
MRLC or GFP-MRLC-DD was injected into 2-cell stage embryos, while DMSO (control) or 
ML-7 was applied at the early 8-cell stage to inhibits MRLC phosphorylation. In control 
embryos, both GFP-MRLC and GFP-MRLC-DD were polarised to the cell contact-free surface, 
consistent with earlier observations (Figure 3.3). ML-7 treatment effectively abolished the 
cortical accumulation of GFP-MRLC (Figure 3.17A-B), however GFP-MRLC-DD was still 
able to accumulate and polarise to the cell contact-free surface (Figure 3.17A-B) upon ML-7 
treatment, indicating that in agreement with previous studies GFP-MRLC-DD can form 
myosin II filaments in the absence of MRLC phosphorylation.  
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Figure 3.16 Phosphomimetic MRLC mutant bypasses the requirement of MRLC 
phosphorylation to form Myosin II filaments.  (A) Embryos expressing GFP-MRLC, GFP-
MRLC-DD were treated with DMSO or ML-7 and stained for GFP. Squares indicate the 
magnified region; Arrows indicate the membrane localised GFP-MRLC or GFP-MRLC-DD. 
(B) Quantification of the percentage of polarised cells in embryos expressing GFP-MRLC or 
GFP-MRLC-DD and treated with DMSO or ML-7. Data are shown as contingency table; the 
numbers show in each bar indicate the number of cells analysed. N = 18 embryos for 
DMSO + MRLC, N = 17 embryos for ML-7 + MRLC, N = 15 embryos for DMSO + MRLC-
DD, N = 18 embryos for ML-7 + MRLC-DD, two independent experiments.****p<0.0001; 
Fisher’s exact test.  
 
 
To test whether PKC activates actomyosin through MRLC phosphorylation and thus myosin 
II filament formation, GFP-MRLC or GFP-MRLC-DD were overexpressed at the 2-cell stage, 
and PKC inhibitors Sphingosine and Calphostin C, PLC inhibitor U-73122 and PLC-DN were 
used as described earlier. Consistent with earlier observations, upon PKC or PLC inhibition, 
GFP-MRLC lost its apical accumulation (Figure 3.18). However, in contrast with ML-7 
treatment, GFP-MRLC-DD was also unable to localise to the apical domain in all treatment 
conditions.  
 
Together, these results suggest that PKC triggers actomyosin activation and therefore apical 
domain establishment through a MRLC phosphorylation independent method.  





Figure 3.17 PKC recruits MRLC to the membrane in a phosphorylation independent 
manner. (A) Embryos overexpressing GFP-MRLC or GFP-MRLC-DD with Ruby (control) 
or PLC-DN were fixed at the late 8-cell stage and stained GFP. Arrows indicate the apical 
recruitment of GFP-MRLC. (B) Quantification of percentage of polarised cells in embryos 
expressing GFP-MRLC or GFP-MRLC-DD and overexpressing Ruby or PLC-DN. Data are 
shown as a contingency table; the numbers in each bar indicate the number of cells analysed. 
N = 17 embryos for Ruby + MRLC, N = 17 embryos for PLC-DN + MRLC and N = 17 
embryos for PLC-DN + MRLC-DD, three independent experiments. ns, not significant; 
****p<0.0001; Fisher’s exact test. (C) Embryos overexpressing GFP-MRLC or GFP-MRLC-
DD treated with DMSO or U73122 were fixed at the late 8-cell stage and stained for GFP. 
Arrows indicate the apical recruitment of GFP-MRLC. (D) Quantification of percentage of 
polarised cells in embryos expressing GFP-MRLC or GFP-MRLC-DD treated with DMSO or 
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U73122. Data are shown as contingency table; the numbers show in each bar indicate the 
number of cells analysed. N = 11 embryos for DMSO + MRLC, N = 11 embryos for 
U73122 + MRLC and N = 9 embryos for U73122 + MRLC-DD, four independent experiments. 
ns, not significant; ****p<0.0001; Fisher’s exact test. (E) Embryos overexpressing GFP-
MRLC or GFP-MRLC-DD treated with DMSO or Sphingosine were fixed at the late 8-cell 
stage and stained for GFP. Arrows indicate the apical recruitment of GFP-MRLC. (F) 
Quantification of the percentage of polarised cells in embryos expressing GFP-MRLC or GFP-
MRLC-DD treated with DMSO or Sphingosine. Data are shown as a contingency table; the 
numbers show in each bar indicate the number of cells analysed. N = 20 embryos for 
DMSO + MRLC, N = 9 embryos for sphingosine + MRLC and N = 20 embryos for 
sphingosine + MRLC-DD, two independent experiments. ns, not significant; ****p<0.0001; 
Fisher’s exact test. All scale bars, 15µm. 
 
 
3.6.2 PKC inhibition inhibits RhoA apical polarisation 
Actomyosin cortical accumulation requires not only myosin II filament formation but also the 
local rearrangement of the actin lattice. A common actin modifier are the Rho GTPases (such 
as RhoA/B/C family), which are known to promote actin polymerisation and branching. 
Consistently, RhoA inhibition abolished both GFP-MRLC and Pard6 apical polarisation 
(Figure 3.19A-D). It was therefore hypothesised that RhoA might act downstream of PKC to 
trigger actomyosin cortical accumulation. To monitor whether RhoA activity is affected by 
PKC, the mRNA of an advanced form of the Förster resonance energy transfer (FRET) based 
RhoA sensor (Raichu-RhoA-CR) was injected into 2-cell stage embryos and the RhoA activity 
was monitored during the 8-cell stage of development. RhoA activity was initially 
homogeneous along the cell membrane, as the embryo compacted it was gradually restricted 
to the cell contact-free surface, and at the late 8-cell stage RhoA was downregulated and its 
activity was limited to a defined region of cell contact-free surface, recapitulating the 
actomyosin ring structure (Figure 3.20A). Upon PLC inhibition by U-73122 treatment, the 
activated RhoA failed to polarise to the cell contact-free surface but instead was slightly 
enriched at the regions of cell contact (Figure 3.20A-B), suggesting that the PLC-PKC pathway 
is required for polarisation of the activated RhoA to the cell contact-free surface. The RhoA 
inhibition by C3-transferase did not block the initiation of cytokinesis yet did lead to the failure 
of the completion of cytokinesis during the following development and the embryos failed to 
form a proper blastocyst at E3.5 (data not shown).  




Figure 3.18 RhoA inhibition abolished actomyosin and Par complex apical polarisation. 
(A) Embryos expressing GFP-MRLC treated with Water (control) or C3-transferase were fixed 
at the late 8-cell stage and stained for GFP and Pard6. Squares indicate the magnified region. 
The arrows indicate the cell contact-free surface. (B) Quantifications of the percentage of 
embryos that showed polarised Pard6. ****p<0.0001, Fisher’s exact test. 2 independent 
experiments). (C) Quantifications of the percentage of cells that showed polarised Pard6. 
****p<0.0001, Fisher’s exact test. (D) Quantifications of the percentage of cells that showed 















Figure 3.20 Activated RhoA failed to polarise to the cell contact-free surface upon the 
inactivation of PLC-PKC pathway. (A) Embryos expressing Raichu-RhoA-CR were imaged 
at the late 8-cell stage. (B) Quantifications of RhoA-FRET ratio between cell contact-free and 
cellcontact cortex in relation to interblastomere angle with cells treated with DMSO or U73122. 
Each dot represents one analysed cell. (N=14-16 embryos, 4 independent experiments). All 
scale bars, 15µm. 
 
3.6.3 RhoA re-activation rescues actomyosin apical recruitment and polarity defects 
driven by PLC-PKC inhibition  
To functionally test whether RhoA acts downstream of PLC-PKC to trigger actomyosin 
cortical accumulation and thus apical domain formation, the PLC-DN was overexpressed at 
the 2-cell stage to inhibit PLC activity, and a constitutively active form of RhoA (RhoA-Q63L) 
was injected into 2 blastomeres of early 4-cell stage embryos. This RhoA mutant lost the ability 
to convert GTP to GDP and therefore kept the RhoA constitutively active (Longenecker et al., 
2003).  In all groups, GFP-MRLC was co-injected to visualise MRLC localisation. The 
embryos were fixed at the late 8-cell stage and stained for GFP (for GFP-MRLC) and Pard6. 
As expected, GFP-MRLC and Pard6 polarised to the cell contact-free surface in the control 
embryos (GFP-MRLC and Ruby overexpression) (Figure 3.21A). Upon U-73122, GFP-MRLC 
lost the apical localisation and Pard6b failed to polarise to the cell contact-free surface (Figure 
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3.21B-D). However, with RhoA-Q63L overexpression, GFP-MRLC re-accumulated to the cell 
contact-free surface, and Pard6b was also effectively re-polarised to the cell contact-free 
surface (Figure 3.21B-D), suggesting that the activated RhoA rescued PLC-DN, and caused 





Figure 3.19 RhoA activity rescues the actomyosin and Par complex polarisation defects 
upon PLC-PKC pathway inhibition. (A) Scheme of rescue strategy. Ruby (control) or PLC-
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DN mRNA were injected at the 2-cell stage into both blastomeres. At the early 4-cell stage 2o 
out of 4 blastomeres were injected with GFP-MRLC only or with RhoA-Q63L. (B) Embryos 
overexpressing different combinations of Ruby, PLC-DN, GFP-MRLC or RhoA-Q63L were 
fixed at the late 8-cell stage and stained for GFP and Pard6. Squares indicate the magnified 
region. Arrows indicate the apical domain. (C) Quantifications of the percentage of cells that 
showed polarised Pard6 localisation pattern with Ruby, PLC-DN or PLC-DN or RhoA-Q63L 
overexpression. ns, not significant; ****p<0.0001; Fisher’s exact test. (D) Quantification of 
cells showed polarised GFP-MRLC. **p<0.01; p<0.0001; Fisher’s exact test. N = 17 embryos 
for Ruby, N = 17 embryos for PLC-DN, N = 18 embryos for PLC-DN + RhoA-Q63L, 2 
independent experiments. All scale bars, 15µm. 
 
The ability of activated RhoA to rescue PLC-PKC phenotype was also tested using U-73122. 
U-73122 was applied at the early 4-cell stage, and RhoA-Q63L was injected into 2 cells of the 
4-cell stage embryo, and cultured in medium containing U-73122 afterwards (Figure 3.22A). 
Similar to PLC-DN experiments, RhoA-Q63L overexpression effectively rescued the 
polarisation of GFP-MRLC and Pard6b (Figure 3.22B-D). 




Chapter III: Results I 
 74	
Figure 3.22 RhoA activity rescues the actomyosin and Par complex polarisation defects 
upon PLC-PKC pathway inhibition. (A) Scheme of rescue strategy. DMSO (control) or 
U73122 were applied from the early 4-cell stage, mRNA encoding GFP-MRLC or with RhoA-
Q63L was injected into 2 out of 4 blastomeres at the 4-cell stage. (B) DMSO or U73122 treated 
embryos expressing GFP-MRLC with or without RhoA-Q63L were fixed at the late 8-cell 
stage and stained for GFP and Pard6. Squares indicate the magnified region. Arrows indicate 
the apical domain. (C) Quantifications of the percentage of cells that showed polarised Pard6 
localisation pattern with DMSO, U73122 or U73122 with RhoA-Q63L overexpression. ns, not 
significant; ****p<0.0001; Fisher’s exact test. (D) Quantification of cells showed polarised 
GFP-MRLC. **p<0.01; ****p<0.0001; Fisher’s exact test. N = 21 embryos for DMSO, N = 17 
embryos for U73122, N = 27 embryos for U73122 + RhoA-Q63L.All scale bars, 15µm. 
  
Together, these results suggest that PLC-PKC activity triggers apical actomyosin accumulation 





Figure 3.20 Summarised model of molecular pathways leading to cell polarity 
establishment. The establishment of cell polarisation can be divided into two phases. In the 
first phase (initiation phase), PLC regulated PKC activity triggers RhoA activation, together 
with MLCK activity which drives actomyosin complex membrane recruitment. The 
actomyosin is excluded from cell contacts and polarises at the cell contact-free surface; in the 
second phase (maturation phase), apical proteins are recruited to the actomyosin enriched cell 
contact-free surface to form an apical domain.  
 





3.7.1 The two phases of the apical domain formation process  
The establishment of cell polarity has been a topic of study in the mouse embryo for decades, 
due to the unique significance of polarisation in developmental progression. More importantly, 
the polarity establishment process in the mouse embryo is de novo, and it is followed by the 
entire epithelialisation process, therefore it is also a valuable in vivo model to study this 
epithelisation process. The results in this chapter describe the division of the cell polarity 
establishment process into two distinct stages: in the first stage, actomyosin polarises to the 
cell contact-free surface, and concomitantly all cells in the embryo compact; in the second 
phase apical proteins are recruited to the cell contact-free surface where they meet the 
actomyosin cortex, and further reorganise the actomyosin into a ring structure by locally 
excluding it. To support this conclusion, we examined a handful of apical domain proteins 
using either immunostaining (for Pard6, aPKC and Crb3) or the overexpression of fluorescence 
tagged constructs (for Ezrin-RFP). Despite that nearly all apical proteins we examined showed 
the same localisation pattern, the sensitivity of the antibodies against specific epitopes would 
need to be taken into consideration. It is possible that the apical proteins already shoed 
polarisation yet the low sensitivity of antibody to detect protein concentration would block the 
detection of such polarisation localisation pattern. Nevertheless, the consistency between 
different apical proteins would still support the conclusion. This crude division of the cell 
polarity establishment process during the 8-cell stage of development also highlights the 
temporal segregation of the compaction and polarisation processes. It has long been thought 
that these two processes occur within an identical time-window, and a causal relationship 
between these two events has been conceived. Yet these results highlight that compaction 
occurs overall slightly earlier than cell polarity establishment. Such a timing discrepancy is not 
surprising, yet it is also uncommon in mammalian embryos, as the high synchronicity of 
compaction and polarisation, that is the compaction and polarisation of all cells within a short 
time-window or developmental stage, seems specific to the mouse. Studies in other mammalian 
species have revealed a great amount of heterogeneity in the timing of cell compaction and 
polarisation, and further a greater distinction in the timing between these two events. For 
example, in porcine embryos compaction takes place at around the 16-32 cell stage, yet cell 
polarisation establishment is only completed at the blastocyst stage (Reima et al., 1993). In 
rabbit embryos, compaction occurs between the 32-64 cell stage and polarisation happens at 
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around the 63 cell stage (Koyama et al., 1994). These timing differences suggest the possibility 
that these two processes are in fact independent of each other. The results shown in this chapter 
provide a clear demonstration of this, as when actomyosin contractility was blocked by 
blebbistatin treatment cell compaction was abolished, yet all cells displayed a normal apical 
domain and polarised. There are also several examples in which the converse is true: when 
ROCK activity is inhibited through pharmacological treatments, the localisation of apical 
domain proteins such as the Par complex was disrupted yet embryos were able to compact 
without any defects. Overall, these results suggest that compaction and polarisation are 
independent processes.  
 
3.7.2 The convergence and divergence of compaction and cell polarisation processes 
during the 8-cell stage development 
So what are the common and specific requirements for compaction and polarisation that lead 
to their independence, and why is actomyosin polarisation specifically associated with 
compaction? Studies suggest that compaction requires a tension difference between the inter-
facial and apical cortex. The generation of membrane tension in turn requires the actomyosin 
network (Maitre et al., 2015). Therefore, it is not surprising to see that the first phase of cell 
polarity establishment, actomyosin polarisation, is accompanied by compaction processes. 
However, for compaction a fully functional actomyosin network is required, that requires not 
only the actomyosin meshwork to be constructed, but also myosin contractility for the 
generation of membrane tension. On the other hand, blebbistatin and ML-7 treatments 
experiment are complementary to each other and suggest that polarisation does not exclusively 
require membrane tension, but it does require an intact actomyosin cortex. Thus it seems that 
the actomyosin cortex functions as a scaffold for apical domain protein recruitment. How the 
actomyosin network helps apical domain protein recruitment is not clear from the results 
presented here. Yet studies in other biological systems or those using in vitro artificial 
biological systems could give some indications. Actomyosin drives apical domain protein 
recruitment and concentration in 8-cell stage blastomeres in a similar manner to that of the T-
cell receptor activation process. In this system, receptors bind to antigens and cluster at the cell 
cortex, locally exclude actomyosin to the periphery. Effective cluster formation requires a 
dynamics actomyosin network that is maintained by the interaction of myosin with the actin 
cortex mediated by Arp2/3 and Cofilin/ADF factors (Huang and Burkhardt, 2007). All three 
factors work together to build a cortex that is mobile enough for inducing, stabilising and 
transporting receptor clusters. Although the contribution of Arp2/3 and Cofilin/ADF to mouse 
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embryo polarity is unknown, it is likely that a myosin-actin interaction is required for building 
a suitable actin network conformation and therefore facilitating Par complex membrane 
mobility. Indirectly in support of this, the inhibition of Myosin II filament formation 
dramatically changed the actin meshwork organisation (Figure 3.6A). Secondly the FRAP 
experiments suggested that the stability of Pard6 was steadily increasing from 4-cell to the late 
8-cell stage. The precise details of how myosin remodels the actin network, and how the 
specific configuration of the actin network aids in the transport of the apical domain proteins 
will need to be further explored.  To address these questions, simulations of the manner in 
which Pard6 cargos would fit into the actomyosin network, and a detailed analysis of the effect 
of each component on the stability and mobility of the Pard6 complex through the application 
of pharmacological treatments targeting myosin, Arp2/3 and Cofilin/ADF may be informative.  
 
3.7.3 The mechanism of PKC/RhoA in the activation of the actomyosin complex  
The various pharmacological treatments targeting PLC, PKC and RhoA individually, together 
with the rescue experiments using the PKC activator or the overexpression of constitutively 
activated RhoA, revealed that the PLC-PKC-RhoA linear molecular pathway is critical for 
apical domain assembly through the regulation of the apical recruitment of the actomyosin 
network.    
 
The downstream pathways of PLC-PKC-RhoA activation of actomyosin remain unexplored. 
PKC is well-known for its function in contractility in muscle tissues, where it increases the 
levels of phosphorylated myosin light chain through the inhibition of myosin light chain 
phosphatase (Etter et al., 2001).  The results described in this body of work demonstrate that 
PKC regulates actomyosin via a different mechanism.  Through the use of a phosphomimetic 
mutant of myosin light chain, MRLC-DD, it was demonstrated that although MRLC-DD seems 
to be able to bypass the requirement of the MLCK mediated MRLC phosphorylation step, it 
still fails to localise to the cell contact free surface upon PLC-PKC inhibition. Therefore, PLC-
PKC regulates myosin phosphorylation through a phosphorylation independent process.  
 
RhoA has long been known as important for polarity establishment in the mouse embryo, 
although the mechanism behind the regulation of polarisation by RhoA remained unknown 
(Clayton et al., 1999). Yet studies in many other systems have always pointed to RhoA’s role 
in the regulation of the actomyosin network (Arnold et al., 2017; Levayer and Lecuit, 2012; 
Ramkumar and Baum, 2016). RhoA has been implicated in playing a role in enhancing 
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actomyosin activity via two different pathways. Firstly, RhoA can enhance MRLC 
phosphorylation by inhibiting myosin phosphatase through its downstream kinase ROCK, in a 
similar manner to the reported mechanism of PKC in elevating MRLC phosphorylation. 
Secondly, RhoA activates several downstream actin re-modellers, such as mDia1 and Arp2/3, 
and thus promotes actin branching and polymerisation. It is possible that RhoA enhances the 
actin-myosin interaction by organising the actin cortex instead of directly phosphorylating 
MRLC. The elevated concentration of myosin II filaments in the actin cortex could further 
induce the changes in actin mesh configurations. A similar phenomenon has been observed in 
the cortical environment during cytokinesis (Chugh et al., 2017).  
 
A FRET based RhoA sensor, Raichu-RhoA-CR, was used to monitor RhoA activity in an 
attempt to determine its role in actomyosin activation and further dissect the timing of cell 
polarity establishment.  From the analysis of normalised FRET ratio, it appeared that RhoA 
activity was homogeneous around the cell membrane prior to the early 8-cell stage, and 
gradually shifted to the cell contact-free surface during compaction. It then further reorganised 
into a ring like structure, reminiscent of the reorganisation of the actomyosin complex at the 8-
cell stage of development (Figure 3.19). Together with the result that the C3-transferase 
treatment abolished MRLC apical recruitment, this data suggests that the change in the 
activated RhoA spatial localisation may guide actomyosin re-organisation over the 8-cell stage 
developmental progression. The application of a PLC inhibitor inhibited the reorganisation of 
activated RhoA. Therefore the PLC-PKC pathway influences the activated RhoA spatial 
organisation which could mechanistically explain how the PLC-PKC pathway affects 
actomyosin polarisation. However, an important question remains of whether PKC activity is 
responsible for elevating RhoA basal activity or whether itis merely responsible for RhoA 
spatial distribution. Three potential mechanisms may apply in this case : 1) PKC may activate 
RhoA through the phosphorylation of RhoA activators such as RhoGEFs, as similar 
mechanisms have been demonstrated in other model systems (Peng et al., 2011). Moreover, in 
support of this idea, the analysis of phosphor-peptides at the cleavage stages of mouse embryo 
development from recent proteomic study suggest that Arhgap1, a RhoA activity regulator is a 
possible downstream target of PKCɑ or PKCβ (Gao et al., 2017). 2) PKC could phosphorylate 
AJ proteins and inhibit RhoA at cell-cell contacts, the boundaries of which have been shown 
in other developmental model systems to be inhibitors of actomyosin activity (Klompstra et al., 
2015). 3) It has been reported that RhoA activation requires oligomerisation mediated by its C-
terminal. Therefore it is also possible that PKC lipid homeostasis aids RhoA oligomerisation. 
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Optogenetic experiments suggest that PLC-PKC activation of the actomyosin cortex is direct, 
therefore making the second possibility unlikely. This also conflicts with the early hypothesis 
whereby PKC phosphorylates AJ and thereby activates some of their functions to trigger cell 
compaction (Winkel et al., 1990). One cannot completely rule out the possibility that PKC 
activation affects AJ stabilisation, yet its role in cell polarisation establishment, or cell contact-
free surface actomyosin activation is more likely to be direct rather than mediated through cell 
contact-free surfaces. A recent report has also suggested that the apical domain assembly is 
independent of the E-cadherin mediated AJ complex (Korotkevich et al., 2017), strengthening 
such a hypothesis. The further determination of the possible mechanisms of PKC activation of 
RhoA would require the identification of the downstream effectors of PKC at the cleavage 
stages. This would require the determination of the mechanism of the corresponding targets in 
the regulation of RhoA activation and therefore actomyosin polarisation.   
 
 
3.7.4 The timing of cell polarity establishment part I: how do PKC and RhoA get 
activated? 
The timing of cell polarity establishment in the mouse embryo is a fascinating question in 
developmental biology. Intriguingly, the immunostaining of the ppMRLC expression profile 
over different developmental stages suggests that actomyosin activation happens around the 
early 8-cell stage and thus is closely associated with the timing of cell polarity establishment. 
The results described in this chapter identified the PKC-RhoA axis as the upstream activator 
of the actomyosin network. Therefore a further question is whether they are activated 
specifically at the 8-cell stage and thus constitute part, if not the whole of the timing mechanism 
for cell polarity establishment. Monitoring the change of PKC activity by traditional 
biochemistry assay is extremely difficult in the mouse embryo due to the scarcity of available 
materials. Some PKC sensors, which utilised DAG or the calcium binding domain of some of 
the PKC isoforms, conjugated with fluorescence proteins have been developed and have been 
used in other cell systems to monitor PKC activation dynamics. However, the application of 
such sensors in the mouse embryos fail to produce any reliable signals (data not shown). It is 
possible that the basal PKC activity in the mouse embryo is low and sensitive, as the application 
of DAG at a low concentration is sufficient to activate compaction in a rapid time-window, and 
leads to a great upregulation of ppMRLC (Figure 3.15A). Some studies report that subtle 
changes of basal activity of PKC can have a significant effect on cell homeostasis (Kirton and 
Loutzenhiser, 1998; Weiner et al., 1997). It is therefore likely that while PKC activation in the 
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mouse embryo may not be as dramatic as in other developmental processes such as fertilisation 
(Gonzalez-Garcia et al., 2013), a subtle activation is nevertheless sufficient to effect 
actomyosin spatial organisation. Taking these possibilities into consideration, a more sensitive 
assay, such as real-time qPCR, could be applied to precisely determine the change of PKC 
activity during different stages of mouse embryo development. The identification of 
transcriptional targets downstream of PKC activation may partially help to address this 
question in the future.   
 
 
3.7.5 Timing of cell polarity establishment part II: what is the missing factor required 
for apical domain assembly? 
Given that the PLC-PKC-RhoA-actomyosin axis is required for triggering cell polarity 
establishment, it is obvious that actomyosin activation and polarisation per se are insufficient 
to trigger the assembly of an intact apical domain, as the matured apical polarity marker Pard6 
failed to respond to actomyosin polarisation and was not recruited to the cell contact-free 
surface, after actomyosin cortical activation at the 4-cell stage (Figure 3.15; Figure 3.16). 
Combined with the fact that the ectopic enhancement of actomyosin activity at the 8-cell stage 
allowed the region of apical domain proteins to expand, it seems likely that unknown factors 
besides actomyosin are specifically responsible for apical protein recruitment, but these only 
appear at the 8-cell stage. These factors may help to connect the actomyosin cortex to the apical 
domain proteins, perhaps by directly binding to apical domain proteins such as the Par complex 
or ERM family members. Potential candidates include the tight junction protein JAM-1 and 
Cdc42. It has been reported that JAM-1 expression is upregulated from the 4-8 cell stage 
(Thomas et al., 2004), and a direct interaction between JAM-1 and the Par complex has been 
reported in epithelial tissues (Ebnet et al., 2004). Although the injection of a JAM-1 antibody 
failed to block cell polarisation (Thomas et al., 1991), it is possible that other members, such 
as JAM-2,3,4, the transcripts of all of which can be detected prior to the 8-cell stage 
(sequencing data from the Zernicka-Goetz lab, unpublished results), function similarly to JAM-
1. A RNAi based knockdown strategy to eliminate all family members may be necessary to 
dissect the potential correlation of JAM proteins with the apical domain assembly. Data from 
studies in epithelial cells, as well as other developmental model systems suggest that Pard6 
membrane localisation can be regulated by other membrane localised Rho GTPases such as 
Cdc42 through the direct binding of Cdc42 to the membrane. It has been recently reported that 
the maternal-zygotic depletion of Cdc42 abolished cell polarisation and led to the reduction of 
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Pard6 apical localisation (Korotkevich et al., 2017), further strengthened this hypothesis. Given 
that Cdc42 depletion disrupts cell polarity establishment at the morula stage, it will be 
important to determine whether the inhibition of Cdc42 can abolish cell polarity from the early 
8-cell stage onward.  And if this were to be the case how does Cdc42 act together with the 
PLC-PKC-RhoA pathway to build the apical domain.  
 
3.7.6 The similarities and differences in polarity establishment between the mouse 
embryo and other developmental systems 
The process of establishing cell polarity at the 8-cell stage in the mouse embryo shares many 
common features with epithelial cell tissues or single cell systems, but is also unique in many 
ways. Studies of cell polarity establishment in numerous systems reveal the importance of 
cytoskeletal networks, including the actomyosin cortex, the microtubule network, the 
intermediate filament cytoplasmic network and septin based cytoskeletal systems in 
establishing cell polarity. Actomyosin or microtubule mediated symmetry breaking processes 
are the most well studied examples. In the 8-cell stage mouse embryo, although it is clear that 
the actomyosin cortex is vital for the establishment as well as the maintenance of cell polarity, 
the inhibition of microtubules failed to interfere with the cell polarity establishment process, 
regardless of the duration of treatment, concentration, or the drugs used (Fleming et al., 1986; 
Pratt et al., 1982) (unpublished observations). Therefore the polarity establishment process in 
the mouse embryo seems to be exclusively regulated by actomyosin. This could partially due 
to the fact the mouse embryo at the earlier stage lacks a classical microtubule organisation 
centre such as a centrosome (Howe and FitzHarris, 2013), and is therefore unable to generate 
polarised transport of the cargos containing polarity proteins to generate the cortical polarity 
as it would in other cases (Siegrist and Doe, 2007). Actomyosin breaking cortical symmetry is 
most well demonstrated in the c.elegans zygote. In this case, the actomyosin flow carries 
anterior Par proteins to the anterior region of the zygote, and through the mutually exclusive 
relationship between anterior and posterior Par proteins the two polarity domains are 
established. The fact that actomyosin polarisation failed to trigger Par complex polarisation 
makes it unlikely that a similar mechanism is used by the mouse embryo specifically at the 8-
cell stage. Nevertheless, it seems that the process of actomyosin flow driven apical domain 
formation is indeed conserved in the mouse embryo but is responsible for apical domain 
formation at other stages. It has recently been reported that during the 8-16 cell stage divisions, 
the apical domain is first disassembled/expanded and is subsequently re-established by the 
actomyosin flow which originates from the cleavage furrow (Zenker et al., 2018).  Although a 
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similar process was not observed at the 8-cell stage, this highlights the diverse pathways that 
are used by the mouse embryo to shape a specialised cortical domain. As has been mentioned 
before, the precise mechanism of actomyosin establishment of the 8-cell stage apical domain 
(de novo cell polarity establishment) requires further and detailed characterisation of actin 
dynamics during the 8-cell stage of development.  
 
In many matured epithelial cells, the extra-cellular matrix (ECM), which is composed of 
integrin, fibronectin and collagen provides extracellular polarity cues to direct the orientation 
and formation of cell polarity. Yet it seems unlikely that a similar mechanism is used for 8-cell 
stage polarity establishment. Firstly, at the 8-cell stage the ECM components are not fully 
synthesized and therefore no matured ECM can be formed at such an early stage. Secondly, 
embedding of the 8-cell stage mouse embryo into ECM coated gels failed to affect the radial 
polarity pattern. Therefore, overall the mouse embryo is another example of de novo cell 
polarity taking place independently of the guidance of the ECM. Although cell adhesion has 
been demonstrated to be the second most common signal that directs cell polarity establishment, 
it also seems dispensable for cell polarity establishment in the mouse embryo, but instead 
merely aids in the acceleration of the process. When un-compacted 8-cell stage blastomeres 
were isolated, in the absence of any cell-cell adhesions, the apical domain could still be 
established at the late 8-cell stage prior to cytokinesis in over half of the cases. And more 
importantly the location of the apical domains appear random with reference to the mid-body 
(cytokinesis bridge), suggesting that the cells do not have a memory of their position in the 
embryo, ruling out the possibility that cell adhesion may still play a role in establishing cell 
polarity (unpublished observations) (Korotkevich et al., 2017). Studies in an artificial in vitro 
actin system suggest that in response to the appropriate concentration of actin monomers and 
its regulators (such as myosin, Arp2/3), the actin cortex can self-organise into a specialised 
domain, similar to the apical domain in the mouse embryo (Abu Shah and Keren, 2014; 
Carvalho et al., 2013). A similar principle may apply in the mouse embryo which could explain 
how the apical domain can be formed in the absence of any external cues.  
 
Studies in epithelial cells revealed that the different polarity domains are maintained by distinct 
and functional polarity complexes, which include: the Crumbs complex and Par complex for 
the apical domain; the Lgl complex and Scribble complex for the basal/basolateral domain 
(Laprise and Tepass, 2011; St Johnston, 2018). All complexes have been demonstrated to 
localise in a similar manner in the mouse embryo, and a similar mutually exclusive relationship 
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exists between different complexes (Hirate et al., 2013; Kono et al., 2014; Stephenson et al., 
2010), suggesting the functional conservation of the core polarity complexes in regulating cell 
polarity in different developmental model systems.  
 
Overall, the results described in this chapter characterised the processes of establishment of 
cell polarity in the mouse embryo, and revealed the signalling molecules that mediate this 
process.  
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Unlike other model systems, the early embryonic cells of the mammalian embryo do not 
polarise until the zygotic developmental stage. In the mouse embryo this happens at the 8-cell 
stage, i.e. 2.5 days’ post-fertilisation. This raises the intriguing question of what regulates the 
timing of cell polarity establishment, allowing its construction at a defined developmental time-
window. The answer to this question would also shed light on mammalian evolution, as the 
timing of cell polarisation displays species specificity.  
 
In this Chapter, the original “inhibitor timing hypothesis” has been re-visited. A new 
hypothesis named “zygotic activator driven hour glass model” has been proposed and the key 
factors regulating the transcriptional programme triggering cell polarisation have been revealed. 
The necessity and sufficiency of such factors has been explored through the use of RNAi, gene-




4.2 Protein synthesis inhibitor treatment did not advance the timing of cell 
polarisation but caused developmental arrest 
It has been postulated that the requirements for cell polarity that commits cells of the mouse 
cleavage stage embryo to their first fate decision are established well in advance, and so the 
destruction of polarity inhibitors remains as the major barrier for cell polarisation prior to the 
8-cell stage. This "inhibitor hypothesis" stemmed from an earlier observation that premature 
polarisation can be induced within several hours when protein synthesis inhibitors are applied 
at the late 2- or early 4-cell stage (Levy et al., 1986). To re-examine the validation of this 
hypothesis, the protein synthesis inhibitor puromycin, used in the early study (Levy et al., 1986), 
and cycloheximide (Schneider-Poetsch et al., 2010) were added from the early 4-cell stage (0-
1 hours post-2-cell stage division) onward and embryos were examined at the late 4-cell (8 
hours post-treatment) and late 8-cell (7 hours post-4 cell stage division) stages. However, 
neither puromycin nor cycloheximide were able to induce precocious cell polarisation at the 
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late 4-cell stage as determined by the localisation of the apical domain protein Pard6 (Figure 
4.1A,B). On the contrary, embryo development fully arrested upon puromycin or 
cycloheximide treatment as neither cytokinesis nor cell polarisation were observed at later 





Figure 4.1 Protein synthesis inhibitors did not trigger premature cell polarisation at the 
late 4-cell stage. (A) Embryos treated with DMSO (as a control), Puromycin or Cycloheximide 
from the early 4-cell stage were fixed at the late 4-cell stage and stained for Pard6 and F-actin. 
(B) Quantifications of polarised cell numbers in embryos treated with DMSO, Puromycin or 
Cycloheximide. Data are shown as a contingency table, the numbers in each bar represent the 
number of cells analysed. N=17 embryos for DMSO, N=16 embryos for Puromycin, N=15 









Figure 4.2 Protein synthesis inhibitors caused embryo developmental arrest and the 
failure of cell polarisation establishment. (A) Embryos with DMSO (as a control), 
Puromycin or Cycloheximide from the early 4-cell stage were fixed at the late 8-cell stage and 
stained for Pard6 and F-actin. (B) Quantifications of polarised cell numbers in embryos treated 
with DMSO, Puromycin or Cycloheximide. Data are shown as a contingency table, the 
numbers in each bar represent the number of cells analysed. N=2 independent experiments. (C) 
Quantifications of total cell number at the late 8-cell stage in embryos treated with DMSO, 
Puromycin or Cycloheximide. Scale bars, 15µm. 
 
4.3 Examining the requirement of zygotic transcripts in triggering cell 
polarisation by blastomere resection 
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To fully understand how the timing of cell polarity is regulated, alternative hypotheses have 
been proposed.  Comparisons with other mammalian species have revealed that the temporal 
correlation between the timing of cell polarity establishment and that of the “maternal-zygotic 
transition” (MZT), during which maternal proteins are rapidly degraded and the zygotic 
genome concomitantly is activated in order to generate new zygotic RNA transcripts (Zernicka-
Goetz et al., 2009). In the mouse embryo this happens during the 2-cell stage, one day before 
cell polarity becomes established. Given this close temporal correlation, it is likely that either 
the maternal degradation releases inhibitory signals to trigger cell polarity, and/or that the 
zygotic transcripts activate cell polarisation by synthesising activators necessary for cell 
polarity establishment. If the zygotic activators exist, it is plausible that their action is 
concentration dependent and that the timing of cell polarity would thus be sensitive to the 
concentration of such factors (Figure 4.3A). Cell volume has been predicted to correlate with 
RNA concentration and specifically, smaller cell size would increase the RNA concentration 
(Padovan-Merhar et al., 2015). Therefore, as an initial attempt to establish whether a zygotic 
activator exists and if so its potential importance for cell polarity, the cytoplasmic volume of 
blastomeres from 2-cell stage or 4-cell stage were experimentally reduced by "blastomere 
resection", a method that does not affect cell fitness or developmental potential (Ciemerych et 
al., 2000; Zernicka-Goetz, 1998). For 2-cell stage resection, one of the two balstomeres were 
resected while for 4-cell stage resection, two blastomeres were randomly resected, and the 
resected or non-resected cells were paired together respectively (Figure 4.3B,E). Indeed, after 
resection the cells maintained their capacity to form blastocysts with all three lineages (Figure 
4.3 C-D, F-G).   
 




Figure 4.3 Zygotic activator driven hour-glass hypothesis and blastomere resection 
experiment illustration. (A) According to the zygotic activator driven hour-glass hypothesis, 
the zygotic transcripts positively regulate cell polarisation and their accumulation beyond a 
certain threshold triggers cell polarisation. This model also predicts that the elevation of zygotic 
transcript concentration advances the timing of cell polarisation. (B) Scheme of blastomere 
resection experiment at the 2-cell stage. One of the blastomeres is resected (30% cytoplasm is 
removed) resulting in the formation of a resected cell and a control cell attached to part of the 
cytoplasm of the resected cell. (C) The 2-cell stage resection procedure did not affect cell 
fitness as the resected cell and control cell were equally capable of forming mini-blastocysts 
with all three lineages. (D) Quantification of the blastocyst formation rate generated from 
control or resected cells. (E) Scheme of blastomere resection experiment at the 4-cell stage. 
The cells were separated and two of the four were resected, the cells were re-aggregated based 
on the size of their cytoplasm. This resulted in the formation of a resected pair and a control 
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pair.  (F) The 4-cell stage resection procedure did not affect cell fitness as the resected cell and 
control cell were equally capable of forming mini-blastocyst with all three lineages. (G) 
Quantification of the blastocyst formation rate generated from control or resected pairs. Data 
are shown as a contingency table, numbers in each bar represent the number of halved embryos 
analysed. Scale bars, 15µm. 
 
 
To track the timing of cell polarity establishment, Ezrin-RFP mRNA was injected into both 
blastomeres of 2-cell embryos and used as an apical polarity marker and then 2-cell or 4-cell 
stage embryos were subjected to resection and the dynamics of Ezrin-RFP were monitored by 
time-lapse imaging until the early blastocyst stage (Figure 4.4A-B; Figure 4.5A-B).  This 
revealed that cell polarity took place faster in the resected cells for both 2-cell stage or 4-cell 
stage embryos, yet the advance of the timing of polarity was more evident when resection was 
performed at the 4-cell stage. Specifically, when the bisection was performed at the 2-cell stage, 
around 59.1% of the cells polarised earlier, compared to only 17.9% of cells with reduced 
volume which polarised at the same time as sister cells and 23.1% of cells with reduced volume 
which polarised later than sister cells (n=39, p<0.0001, hypothetical mean =0, one sample t-
test. Figure 4.4A-C). When the resection was performed at the 4-cell stage, 94.5% of the 
resected cells polarised earlier than their control sister pair cells (n=35, p<0.0001, hypothetical 
mean =0, one sample t-test. Figure 4.5A-C).  




Figure 4.4  Resected cells from 2-cell stage embryo always polarised earlier than control 
sister cells.  (A) Time-lapse imaging of the control sister cells from the 4-cell stage to the 
morula stage. (B) Time-lapse imaging of resected sister cells from the 4-cell stage to the morula 
stage. For all images, squares indicate the magnified regions, the arrows indicate the apical 
domains. (C) Bar chart showing all comparisons of the time difference in polarisation between 
resected and control sister cells from experiment illustrated in b, each bar represents one 
comparison. Note that cells with reduced volume polarised earlier in the majority of cases. The 
time of polarisation is defined as when the first cell becomes polarised in a structure in all 
experiments. Time difference (in hours, h) is calculated as (time when resected cells polarise –
time of control cell polarisation).  n=39 pairs analysed. ****p<0.0001, one-sample t-test, 
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Figure 4.5 Resected cells from 4-cell stage embryo always polarised earlier than control 
sister cells. (A) Time-lapse imaging of the control pairs from the 4-cell stage to the morula 
stage. (B) Time-lapse imaging of resected pairs from the 4-cell stage to the morula stage. For 
all images, squares indicate the magnified regions, the arrows indicate the apical domains. (C) 
Bar chart showing all comparisons of the time difference of polarisation between resected and 
control sister cells from experiment illustrated in b, each bar represents one comparison. Note 
that cells with reduced volume polarise earlier in the majority of cases. The time of polarisation 
is defined as when the first cell becomes polarised in a structure in all experiments. Time 
difference (in hours, h) is calculated as (time when resected cells polarise –time of control cell 
polarisation).  n=39 pairs analysed. ****p<0.0001, one-sample t-test, hypothetical mean =0.  
Scale bars, 15µm. 
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The reduction in blastomere size could potentially affect multiple cellular processes, such as 
cortical tension. Therefore, to further determine whether the advancement of cell polarisation 
timing was indeed due to a transcription-dependent effect, the resected cells from the 2-cell 
stage embryos were subjected to a pulse of 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole 
(DRB)(Bensaude, 2011) treatment (Figure 4.6A) from the mid to late 4-cell stage (roughly 3 
hours). The timing of cell polarisation was then compared to that of the control sister cells. The 
analysis of the cell polarity timing between control sister cells and the resected and DRB treated 
cells revealed that, the short period of DRB treatment repressed the advancement of cell 
polarity establishment (46%, n=15, ns, one-sample t-test)(Figure 4.6B-D), further 
strengthening the hypothesis that the zygotic transcripts’ concentration is associated with the 










Figure 4.6 Inhibition of transcription prevents advancement of timing of cell polarisation. 
A. Scheme of pulsed DRB treatment in 2-cell stage resection experiment. Resection was 
performed at the mid 2-cell stage as indicated in Figure 4.3B. Resected cells were subjected to 
DRB treatment for 3h at the late 4-cell stage followed by time-lapse imaging. B, C. Time-lapse 
imaging of control sister cells and resected + DRB-treated sister cells generated from the 
experiment shown in b. Arrows indicate the apical domain. Asterisks indicate the cytoplasm 
from resected cells.  D. Bar chart shows the time difference between control sister cells and 
resected+DRB-treated cells, each bar represents one comparison. The time difference 
(displayed in hours, h) is defined as the time point at which the first cell becomes polarised in 
a structure, same for all resection related experiments. Time difference (h) is calculated as (the 
time of resected cells become polarised – the time of control cell become polarised). n=15 pairs 
analysed. ns, not significant, one-sample t-test, hypothetical mean =0. Scale bars, 15µm. 
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4.4 Pausing transcription at the early 8-cell stage prevents cell polarity 
establishment  
To further determine the necessity of zygotic transcription for cell polarity establishment, two 
RNA synthesis inhibitors, DRB and Triptolide (Bensaude, 2011), both of which can effectively 
inhibit transcription shortly after application, were added to the medium of embryos cultured 
from the 4-8 cell stage to the 8-16 cell stage (Figure 4.7A).  The cell polarisation was examined 
by Pard6 and F-actin staining. DRB treatment strongly blocked apical domain formation as 
Pard6 and F-actin failed to organise into apical ring structures in majority of the cells (Figure 
4.7B). Interestingly, despite the failure of cell polarity establishment, cytokinesis still occured 
and the cell number between control and treated groups was not significantly different (Figure 
4.7 C-E), suggesting a specific effect of transcription inhibition on cell polarity establishment. 
As DRB is reversible (Bensaude, 2011), to further determine the specificity of transcription 
inhibition in preventing cell polarity, the DRB was washed out, and the cell polarisation status 
as well as the following development were checked every 30 minutes by time-lapse imaging. 
This revealed that the DRB washout allowed re-establishment of cell polarity within 9 hours 
(Figure 4.7 F-H). The treatment with triptolide similarly blocked cell polarity establishment 
without affecting cytokinesis from 8-16 cell stage (Figure 4.8 A-D). These results together 
suggest that, zygotic transcription was required for cell polarisation establishment at the 8-cell 
stage, and more importantly, the requirement of transcription is continuous until the early the 
8-cell stage is still required for a proper timing of cell polarity establishment.  
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Figure 4.7 DRB treatment blocked cell polarisation. (A) Schematic showing embryos 
treated from 4-8-cell stage with transcription inhibitors DRB (50µM) or Triptolide (5 µM) and 
fixed at late 8-cell or 8-16 cell stages (12 hours duration in total). (B) DMSO (control)- or 
DRB-treated embryos fixed at late 8-cell stage and stained for F-actin, Pard6 and DNA. (C) 
DMSO- or DRB-treated embryos fixed at 8-16 cell stage and stained for F-actin, Pard6 and 
DNA. (D) Quantification of Pard6 apical enrichment in cells treated with DMSO or DRB from 
4-8 cell stage or mid 8-cell stage to the late 8-cell stage. Each dot represents an analysed cell. 
Data shown as individual data points with Box and Whiskers plot (bottom: 25%; upper: 75%; 
line: median; whiskers: min to max). ***p<0.001; **** p<0.0001, One-way ANOVA test. (E) 
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Numbers of polarised cells in DMSO- and DRB-treated embryos. Data shown as individual 
data points with Box and Whiskers plot (bottom: 25%; upper: 75%; line: median; whiskers: 
min to max). **** p<0.0001, Student’s t-test. (F) Total cell numbers in DMSO- and DRB-
treated embryos. n=11 embryos, DMSO-treated; n=14 embryos, DRB-treated; ns, not 
significant in Mann-Whitney test. (G, H) Snapshots of time-lapse images of embryos after 
washing out DMSO (F, control) or (G) DRB from early 8-cell stage to late 8-cell stage. (I) Line 
chart shows percentage of polarised cells at different post-wash out time-points in DMSO 
washed-out (control) or DRB washed-out group. For t=0.5h, n=87 cells for DMSO and n=97 
cells for DRB group were analysed; for t=3.5h, n=101 cells for DMSO and n=102 cells for 
DRB group were analysed; for t=9.5h, n=109 cells for DMSO and n=107 cells for DRB were 





Figure 4.8  Triptolide treatment blocked cell polarisation. (A) Embryos treated with DMSO 
(control) and Triptolide were fixed at the late 8-cell stage and stained for Pard6 and F-actin. 
(B) Embryos treated with DMSO (control) and Triptolide were fixed at the late 8-cell stage 
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and stained for Pard6 and F-actin. (C) Quantifications of polarised cell numbers in embryos 
treated with DMSO and Triptolide. (D) Quantification of Pard6 apical enrichment in cells 
treated with DMSO or Triptolide from 4-8 cell stage to the late 8-cell stage. Each dot represents 
an analysed cell. Data shown as individual data points with Box and Whiskers plot (bottom: 
25%; upper: 75%; line: median; whiskers: min to max). **** p<0.0001, Mann-Whitney test. 
(E) Quantifications of total cell numbers in embryos treated with DMSO and Triptolide. Data 
shown as individual data points with Box and Whiskers plot (bottom: 25%; upper: 75%; line: 
median; whiskers: min to max). **p<0.01; ns, not significant. Student’s t-test. Scale bars, 15µm. 
 
4.5 dsRNA screen for candidate zygotic genes for cell polarity establishment at 
the 8-cell stage 
As the blastomere resection and RNA synthesis inhibitor results suggest that ZGA might result 
in zygotic activators triggering cell polarity establishment, revealing the nature of such factors 
would be the key step in understanding the mechanism triggering cell polarity establishment, 
as well as the timing regulation involved. To this end, two different strategies have been used 
to determine the essential zygotic regulators triggering cell polarity establishment.   
  
4.5.1 Strategy no 1: Screen candidates based on gene expression profile as well as 
Gene Ontology terminology  
The first strategy is based on the hypothesis that certain essential cytoskeleton regulators 
accumulate immediately after ZGA and keep doing so until the early 8-cell stage. Their action 
would be concentration dependent, so that once they accumulate beyond a certain threshold 
this would trigger the establishment of cell polarity. This hypothesis could explain the results 
of the blastomere resection experiments as well as those of the RNA synthesis inhibitor 
experiment (as illustrated in the hypothetical model in the blastomere resection experiment, 
Figure 4.4A). To this end, candidate genes were selected after analysis of two published RNA-
seq databases (Deng et al., 2014; Goolam et al., 2016). Two selection criteria were used for the 
candidate genes:  1) upregulation from the 2-8 cell stage 2) have potential functions in 
cytoskeletal regulation and cell polarity establishment. To this end, the genes displaying 
consistent upregulation from the 2-8 cell stage in both databases were filtered out, the GO (gene 
ontology) term for each gene was determined using the Uniprot website 
(http://www.uniprot.org) and the genes labelled with cytoskeletal regulation, cell polarity, and 
Rho GTPase regulation were preferentially selected. Around 5621 genes displayed 
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upregulation from the 2-8 cell stage (Table 1). Based on the GO terms and previous studies in 
other systems, 114 genes were selected for the primary screen (Table 1). 
 
Gene Symbol Gene Symbol Gene Symbol Gene Symbol Gene Symbol 
Als2 Celsr2 Igf1r Plekgh2 Tmem92 
Amhr2 Celsr3 Igf2r Ppp1ca Trp63 
Ap2m1 Cfl1 Itgae Psap Vangl1 
Arhgap1 Cfl2 Jup Psen1 Vangl1 
Arhgap10 Cttn Krtcap2 Ptpn18 Vangl2 
Arhgap12 Dlg5 Lgr4 Rack1 Wdr83 
Arhgap19 Dstn Llgl2 Rbpj Xab2 
Arhgap28 Efna1 Lpar1 Rhgdia Ywhab 
Arhgap29 Efna2 Lpar5 Ripor1 Ywhae 
Arhgap5 Fabp3 Lpar6 Rnd1 Ywhah 
Arhgap8 Fabp5 Lrg1 Rnd2 Ywhaq 
Arhgdig Fam89b Mapt Rnd3 Zfp740 
Arhgef16 Gabpa Marcks Rps11 Gata1 
Arhgef3 Glrx3 Marcksl1 S1pr2 Gata3 
Arpc3 Gmfg Mark3 S1pr5 Gata4 
Arpc5 Gpr136b Mesdc2 Snx5 Tfap2c 
B4galt1 Gpr160 Mybp3 Sphk1 Tead4 
Cap1 Gpr160 Net1 Sphk2 Pou5f1 
Capzb Gpr171 Oog1 Spint1  
Ccdc43 Gpr172b P2y14 Stub1  
Cd9 Gpr19 Pdzd3 Sycn  
Cdc151 Gpr50 Pfn1 Tagln2  
Cdc42ep1 Gprc50 Pkm Taxbr2  
Cdc42ep5 Gprc5a Pkn2 Tdgf1  
Celsr1 Hand1 Pkn3 Tm4sf1  
 
Table 4.1 The selected candidate list for the RNAi screen. The selection criteria were: 1) 
Upregulation from the 2-8 cell stage in published RNA-seq datasets. 2) Gene ontology terms 
related to cytoskeletal regulation, cell polarity, Rho GTPase regulation. Highlights show 
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genes that display a phenotype. Cells coloured in blue = cell proliferation defect.  Cells 
coloured in green = polarisation delay.  
   
One or two dsRNAs were designed to deplete each candidate. Each dsRNA was 300-500nt in 
length and within the CDS region. For the genes with multiple transcription variants the 
common CDS region was selected.  For the initial screen, 2-3 dsRNAs were grouped together 
(based on the potential functional redundancy) and injected into the zygote (Table 4.2). The 
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Als2; Ap2m1 Gabpa; Glrx3; Gmfg Ywhab; Ywhae; Ywhah 
Amhr2; Oog1 Ywahq 
Arhgap1; Arhgap5;Arhgap10 Plekgh2 Zfp740 
Arhgap12; Arhgap19 Ppp1ca Gata1 
Arhgap28; Arhgap29 Psap Gata3 
Arhgap8;  Psen Gata4 
Arhgef16; Arhgef3 Ptpn18 Tfap2c; Tead4 
Arpc3; Arpc5 Rbpj Pou5f1 
B4Galt1;  S1pr2; S1pr5  
Cap1; Capzb Arhgdig; Arhgdia;Ripor1  
Ccdc43 Rnd1; Rnd2; Rnd3  
Cd9; Cd151 Sphk1; Sphk2  
Cdc42ep1; Cdc42ep5 Stub1  
Celsr1; Celsr2; Celsr3 Spint1  
Cfl1; Cfl2; Dstn Snx5  
Efna1; Efna2 Sycn  
Fabp3; Fabp5 Tagln2  
Cttn; Rack1 Taxbr2  
Fam89b;Jup Tdgf1  
Marcks; Marcksl1 Tm4sf1  
Gpr136b; GPR160; Grp172 Tmem92  
Gpr19; Gpr50; Gprc5a Trp63  
Gpr171; P2y14 Vangl1; Vangl2  
Igf1r; Igf2r Wdr83  
Pkn2; Pkn3 Xab2  
Als2; Ap2m1 Gabpa; Glrx3; Gmfg  
 
Table 4.2 The combination of candidate genes for dsRNA injections. The dsRNAs of the 
candidate genes belonging to the same protein families or implied to have similar biological 
functions (up to three genes) were pooled together and injected into the zygote. Each cell 
represents one injection condition.  
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The initial analysis revealed a couple of candidates the depletion of which resulted in 
preimplantation phenotypes, including: 1) Xab2, a factor that constitutes a pre-mRNA splicing 
complex (Kuraoka et al., 2008), and the depletion of which caused a failure of morula to 
blastocyst transition. 2) Rps11, a ribosomal protein (Lott and Mackie, 1988) whose depletion 
lead to the failure of embryo cavitation and resulting in cell death at the blastocyst stage (not 
shown). However, all the remaining candidate failed to show a phenotype and did not affect 
cell polarisation at the late 8-cell stage. 
  
4.5.2 Strategy no 2: screen transcription factors active around the 8-cell stage based 
on ATAC-seq data. 
The proximate requirement of transcriptional activity for cell polarity establishment suggests 
that the transcriptional program triggering cell polarity establishment may be under stage 
specific developmental control. In many embryonic developmental processes stage specific 
morphogenetic transitions are generally regulated by transcription factor activities (Meech et 
al., 2005; Shahbazi et al., 2017; Wang et al., 2013). Therefore, it is likely that certain 
transcription factors are active at the early 8-cell stage or at an earlier stage, and these activate 
downstream targets necessary for cell polarity establishment. To this end, a recently published 
ATAC-seq dataset was analysed (Wu et al., 2016), which revealed several transcription factors 
the activities of which were upregulated from the 2-8 cell stage and appeared highest around 
the 8-cell stage. These transcription factors included Tead4, Gata1, Gata3, Gata4, Pou5f1 and 
Tfap2c (Wu et al., 2016). To their potential role in cell polarity establishment, a dsRNA 
targeting each gene was designed and injected at the zygote stage to deplete protein expression, 
while Ezrin-RFP was co-injected to visualise polarity dynamics. As a control, dsRNA targeting 
GFP with Ezrin-RFP was injected. The efficiency for each dsRNA was verified by 
immunostaining or RT-qPCR (Figure 4.9A-F). The effects on cell polarity establishment were 
examined by time-lapse imaging.  This revealed that the depletion of Gata1, Gata3, Gata4 and 
Pou5f1 did not significantly affect cell polarity establishment, as by the late 8-cell stage the 
majority of the cells could successfully polarise, and formed the ring structure on the cell 
contact-free surface (Figure 4.10 A,F). However, the depletion of Tead4 and Tfap2c 
significantly reduced the number of polarised cells at the late 8-cell stage, although cytokinesis 
was not significantly affected (Figure 4.10 B-E, G).  However the cell polarity defects caused 
by Tead4 or Tfap2c depletion seemed to be transient, as by the 16-cell stage the majority of 
the cells re-established an apical domain (Figure 4.10 B-E, H). To test whether these two 
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factors could compensate for one another, a dsRNAs targeting the transcripts of both genes 
was co-injected into the zygote, together with Ezrin-RFP to visualise polarity. The co-depletion 
caused a more severe phenotype, as the number of cells that polarised with Pard6 and Ezrin at 
the late 8-cell stage was further reduced, and more importantly, even at the 16-cell stage the 
majority of cells still failed to form an apical domain (Figure 4.10B-E, H, I-J). Thus the co-
depletion of Tfap2c and Tead4 caused a more severe phenotype than single depletion, and 
therefore it is evident that both Tfap2c and Tead4 are required for cell polarity establishment, 
and moreover they exhibit functional redundancy. Tfap2c (also known as AP2gamma, Tcfap2c) 
belongs to the Activating Protein 2 (AP-2) family which has been revealed to be involved 
widely in early development (Hilger-Eversheim et al., 2000). Tead4 belongs to the 
transcriptional enhancer factor (TEF) transcription factor family, and it is well known for its 
role in regulating TE and trophoblast specification and differentiation(Yagi et al., 2007).   
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Figure 4.9 Validation of dsRNA targeting different transcription factors active at the 8-
cell stage. (A) Embryos injected with dsRNA targeting GFP (control) or Gata4 were fixed at 
the late 8-cell stage and immunostained for Gata4. (B) Embryos injected with dsRNA targeting 
GFP (control) or Pou5f1 were fixed at the late 8-cell stage and immunostained for Pou5f1. (C) 
Embryos injected with dsRNA targeting GFP (control) or Tfap2c were fixed at the late 8-cell 
stage and immunostained for Tfap2c. (D) Embryos injected with dsRNA targeting GFP 
(control) or Tead4 were fixed at the late 8-cell stage and immunostained for Tead4. (E) 
Expression level of Gata1 in embryos injected with dsRNA targeting GFP or Gata1. (F) 
Expression level of Gata3 in embryos injected with dsRNA targeting GFP or Gata3. Scale bars, 
15µm. 
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Figure 4.10 dsRNA-mediated knockdown of Tfap2c and Tead4 led to the delay of cell 
polarisation at the late 8-cell stage. (A) Embryos injected with Ezrin-RFP and dsRNA 
targeting GFP (control), Gata1, Gata3, Gata4, Pou5f1were scanned at the late 8-cell stage for 
Ezrin. (B,C,D,E) Snapshots of time-lapse imaging of embryos expressing Ezrin-RFP and 
dsRNAs targeting GFP (B), Tfap2c (C), Tead4 (D) and Tfap2c+Tead4 (E) from the late 8-cell 
stage to the early 16-cell stage. Arrows indicate the apical domains. (F) Quantifications of the 
number of polarised cells in embryos expressing dsGFP, dsGata1, dsGata3, dsGata4 and 
dsPou5f1 at the late 8-cell stage. (G) Quantifications of the number of polarised cells in 
embryos expressing dsGFP, dsTfap2c, dsTead4 and dsTfap2c+dsTead4 a the late 8-cell stage. 
*p<0.05, ***p<0.001, ****p<0.0001; Kruskal-Wallis test.  (H) Quantifications of number of 
polarised cells in embryos expressing dsGFP, dsTfap2c, dsTead4 and dsTfap2c+dsTead4 at 
the early 16-cell stage. ns, not significant; ****p<0.0001; Kruskal-Wallis test. (I) Embryos 
injected with dsGFP or dsTfap2c+dsTead4 were fixed at the late 8-cell stage and stained for 
Pard6, F-actin and DNA. Arrows indicate the apical domains. (J) Quantifications of Ezrin 
apical enrichment in the cells expressing dsGFP or dsTfap2c+dsTead4. The apical enrichment 
is calculated as the signal intensity of Ezrin at the cell contact-free domain against the signal 
intensity of Ezrin at the cell-cell contacts. Data shown as individual data points with Box and 
Whiskers plot (bottom: 25%; upper: 75%; line: median; whiskers: min to max). ****p<0.0001, 
Student’s t-test. Scale bars, 15µm. 
 
 
4.6 A CRISPR-Cas9 method to genetically deplete Tfap2c and Tead4  
The polarity phenotypes observed as a result of downregulation of Tfap2c and Tead4 were 
surprising, as no polarity defects were observed for single knockout embryos of Tfap2c or 
Tead4 at later stages. RNAi methods can potentially give off-target effects (Jackson et al., 
2003). To validate the specificity of the phenotype resulting from RNAi targeting of Tfap2c 
and Tead4, and substantiate the role of these two factors in the regulation of cell polarity, the 
CRISPR-Cas9 method was employed to genetically deplete Tfap2c and Tead4. To achieve this, 
three independent sgRNAs targeting a single exon were designed using an optimised CRISPR 
design website (http://crispr.mit.edu). sgRNAs were spaced out at over 20-50nt intervals. A 
similar design has been reported to have a very high efficacy at causing genomic mutations 
(Zuo et al., 2017) (Figure 4.11A). The three sgRNAs for each gene, together with Cas9 mRNA 
and Ezrin-RFP (to visualise polarisation) were co-injected at the zygote stage, and 8-16 cell 
stage embryos were collected for immunostaining for the target genes (Figure 4.11A). The 
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immunostaining for Tfap2c and Tead4 revealed that by the 8-16 cell stage, the cells injected 
with sgRNAs and Cas9 displayed various levels of expression of Tfap2c or Tead4, in contrast 
to the control group in which all cells displayed high levels of Tfap2c and Tead4 (Figure 4.11B-
C). The cells with a low level of Tfap2c or Tead4 were considered to be Tfap2c-null or Tead4-
null cells. Overall, majority of the embryos injected with Cas9 and sgRNA targeting Tfap2c or 
Tead4 displayed mosaic pattern of Tfap2c or Tead4 expression level at the 8-16 cell stage 
(80%), only in around 20% of the embryos, all blastomeres remain low level of Tfap2c or 
Tead4. In embryos injected with only Cas9, all cells have high level of Tfap2c or Tead4 (100%).  
The quantification of cell polarisation suggested that the percentage of polarised cells in Tead4-
null embryos did not differ significantly from the Cas9 only (control) group, suggesting that 
the Tead4 single knockout cells polarised (Figure 4.11D-F). On the contrary, the Tfap2c-null 
embryos displayed a reduction in the number of polarised cells, yet there was a certain 
proportion of cells that polarised (Figure 4.11 D-F), suggesting that Tfap2c depletion alone did 
not prevent cell polarisation completely.  
 
To test whether the co-depletion of Tfap2c and Tead4 together could yield a more severe 
phenotype, as suggested by the RNAi experiment (section 3.5), sgRNAs for both Tfap2c and 
Tead4, together with Cas9 and Ezrin-RFP mRNAs were injected at the zygote stage and the 
embryos were fixed at the late 8-16 cell stage and stained for Tfap2c and Tead4 (Figure 4.11A). 
The quantification of cell polarisation in the Tfap2c-, Tead4-null (double depletion) group 
suggested that none of the cells were able to polarise at the 8-16 cell stage when Tfap2c and 
Tead4 were both depleted (Figure 4.12A). Together, the gene editing experiments along with 
the RNAi results, strongly suggest that Tfap2c and Tead4 mediated transcriptional activity is 
crucial for cell polarity establishment at the 8-cell stage.  
 
 




Figure 4.11 CRISPR strategy to deplete Tfap2c and Tead4 from the zygote stage 
generated cells expressing different levels of Tfap2c and Tead4. (A) Schematic of the 
CRISPR-cas9 strategy used to deplete Tfap2c and Tead4.  (B) Signal intensity quantification 
in cells that showed a strong, medium or low level of Tfap2c (classification was shown in 
squares). Representative images of cells expressing different levels of Tfap2c are shown on the 
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right. Each dot represents a single analysed cell (n=23 embryos). The normalised signal 
intensity below 0.1 was considered to represent a “Tfap2c-null” cell.   All cells were from 
embryos injected with Cas9 and gRNAs targeting Tfap2c, and immunostained with anti-Tfap2c 
and DAPI at 8-16 cell stage. b. Quantifications of the signal intensity for cells that showed a 
strong, medium or low level of Tead4 (classification denoted in squares). Each dot represents 
a single analysed cell (n=16 embryos). Representative images of cells expressing different 
levels of Tead4 are shown on the right. Each dot represents a single analysed cell. A cell with 
a normalised signal intensity below 0.6 was considered a “Tead4-null” cell. All cells are from 
embryos injected with Cas9 and sgRNAs targeting Tead4 and stained for Tead4 and DNA at 





Figure 4.12 Genetic depletion of Tfap2c and Tead4 by CRISPR technology abolished cell 
polarity at the late 8-cell stage. (A) Representative images of embryos expressing Ezrin-RFP 
with wild-type (injected with only Cas9 mRNA, control); single depletion of Tfap2c (injected 
with Cas9 and sgRNAs targeting only Tfap2c); single depletion of Tead4 (injected with Cas9 
and sgRNAs targeting only Tead4 sgRNAs); double depletion of Tfap2c and Tead4 (injected 
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with Cas9 and sgRNAs targeting both Tfap2c and Tead4) fixed at the 8-16 cell stage and 
stained for Tfap2c and Tead4. (B) Representative images of embryos expressing wild-type 
(injected with only Cas9 mRNA, control); single depletion of Tfap2c (injected with Cas9 and 
sgRNAs targeting only Tfap2c); single depletion of Tead4 (injected with Cas9 and sgRNAs 
targeting only Tead4); double depletion of Tfap2c and Tead4 (injected with Cas9 and sgRNAs 
targeting both Tfap2c and Tead4) fixed at the 8-16 cell stage and stained for Tfap2c, Tead4 
and Pard6. (C) Proportions of polarised blastomeres in different genotypes presented in m. 
Data presented as contingency table. Number of cells analysed presented within each bar. ns, 
not significant; ****p<0.0001, Fisher’s exact test. Cells showing Ezrin apical enrichment are 
polarised (quantification of Ezrin apical/basal signal intensity ratio displayed in D). (D) 
Quantifications of Ezrin apical enrichment in Cas9 only (control), Tfap2c-null, Tead4-null and 
Tfap2c- and Tead4-null cells. Data shown as individual data points with Box and Whisker plots 
(lower: 25%; upper: 75%; line: median; whiskers: min to max). n=20 cells for Cas9 only, n=9 
cells for Tfap2c-null, n=20 cells for Tead4-null and n=12 cells for Tfap2c and Tead4-null.N=3 
independent experiments. Ezrin apical enrichment is calculated as Iapical-Ibasal (Methods). 
**p=0.0012, ***p=0.0007, ****p<0.0001, Kruskal-Wallis test. Scale bars, 15µm. 
 
4.7 Tfap2c and Tead4 protein showed nuclear accumulation after ZGA and their 
depletion affected gene expression at the early 8-cell stage. 
Both Tfap2c and Tead4 have been implicated in regulating preimplantation development but 
at later stages than those examined in this study. Tfap2c has been previously shown to promote 
TE development from pre to post-implantation stages by partially controlling the expression of 
Pard6b and tight junction components at the blastocyst stage (Cao et al., 2015; Choi et al., 
2012). Tead4 is a known master regulator of TE specification and differentiation (Nishioka et 
al., 2008; Yagi et al., 2007). Therefore, in order for their potential function at earlier 
developmental stages and their relationship with the establishment of cell polarisation to be 
examined, the mRNA and protein levels of each gene were analysed using single-cell RNA 
sequencing data (previously available dataset in the Zernicka-Goetz lab), and immunostaining 
(Figure 4.13A-C). The single cell RNA-seq data indicated that Tfap2c is expressed at the 
zygote and 2-cell stage, suggesting a maternal contribution, but its expression declines during 
the 2-4 cell stage transition and subsequently increases between the 4-8 cell stage (Figure 
4.13A), in agreement with another report. In contrast, Tead4 is expressed from the 2-cell stage 
and its expression steadily increases until the 8-cell stage (Figure 4.13A). Importantly, 
expression of both Tfap2c and Tead4 proteins is low or barely-detectable at the mid 2-cell stage, 
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but increases progressively throughout pre-implantation development, indicating a 
contribution of both transcription factors through ZGA.  
  
The earlier analysis of the single-cell RNA-seq data suggested that several genes encoding 
cytoskeletal regulatory proteins are dramatically upregulated at the 4-8 cell stage transition 
(section 3.5.1). Furthermore, it was observed that upon downregulation of either Tfap2c or 
Tead4, these genes are downregulated further concurring with ATAC-seq data indicating that 
Tfap2c and Tead4 are active at early stages such as the early 8-cell stage before cell polarity is 
established. 
  
Together, these data suggest that Tfap2c and Tead4 are upregulated after ZGA, and are active 





Figure 4.13 Expression profile of Tfap2c and Tead4 from the 2-cell to the 8-16 cell stage. 
(A)  Expression profile of Tfap2c and Tead4. Data are presented as means ± S.E.M. (B) 
Expression profile of Tfap2c and Tead4 proteins from the 2-cell to the morula stage.  (C) 
Quantification of Tfap2c and Tead4 nuclear protein levels from the 2-cell to the 8-16 cell stage. 
Data are presented as mean ± S.E.M. n=7 embryos for the 2-cell stage; n=15 embryos for  the  
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4-cell stage; n=26 embryos for early the 8-cell stage; n=17 embryos for the 8-16 cell stage. 
N=2 independent experiments. Scale bars, 15µm. 
 
4.8 Tead4 expression regulates early Yap nuclear localisation 
To activate its downstream targets, Tead4 requires the co-activator Yap/Taz proteins. 
Paradoxically, the nuclear localisation of Yap/Taz at the late morula stage (16-32 cell stage) is 
known to be downstream of apical domain activity. However, a recent study revealed that 
nuclear accumulation of Yap occurs before apical domain formation, and disruption of the 
apical domain has no significantly effect on Yap’s nuclear localisation prior to the 16-cell stage. 
This suggests that an apical-domain independent mechanism regulates nuclear yap localisation 
at the early 8-cell stage. To fully understand the manner in which Tead4 regulates downstream 
gene expression prior to apical domain formation, Yap’s nuclear localisation in relation to 
Tead4 expression was examined. This revealed that, in an agreement with earlier reports, Yap 
gradually localised to the nucleus (Figure 4.14A-B) prior to apical domain establishment from 
the 2-8 cell stage onward (Figure 4.14A-B). Moreover, a comparison with the Tead4 nuclear 
protein level revealed that Yap’s nuclear localisation correlated with Tead4 prior to the early 
8-cell stage (Figure 4.14C).  
 
 




Figure 4.14 Yap nuclear localistaion correlates with Tead4 expression profile from 2-8 ell 
stage. (A) Expression profile of YAP and Tead4 from the 2-cell to 8-16 cell stage.  (B) 
Quantification of YAP nuclear/cytoplasm (N/C) ratio from the 2-cell to the early 8-cell stage. 
Data presented as means ± S.E.M. n=10 cells for the 2-cell stage, n=13 cells for the 4-cell stage, 
n=21 cells for early the 8-cell stage. N=2 independent experiments. (C) Positive correlation 
between Tead4 nuclear expression and YAP nuclear/cytoplasm ratio, each dot represents one 
analysed cell. R2 = 0.7168, p<0.0001. Scale bars, 15µm. 
 
This correlation raised the question of whether Tead4 plays a role in regulating Yap’s early 
nuclear import. To address this, Tead4 expression was experimentally altered (either through 
over-expression or knock-down), and the impact on Yap localisation was examined. The 
reduction of Tead4 expression by RNAi significantly diminished Yap’s nuclear localisation at 
the early 8-cell stage (Figure 4.15A-B) and conversely, Tead4 over-expression resulted in a 
dramatic up-regulation of Yap’s nuclear localisation by the early 8-cell stage (Figure 4.15C-
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D). Together, these data suggest that prior to cell polarity establishment, the accumulation of 
Tead4 protein during the 2-8 cell stage spontaneously leads to the recruitment of its co-activator 






Figure 4.15 Tead4 expression regulates Yap nuclear localisation. (A) Representative 
images of embryos injected with Ezrin-RFP mRNA only (control), dsTead4 and 
dsTead4+Tfap2c RNAs, fixed at early 8-cell stage and immunostained to reveal YAP. (B) 
Quantification of YAP N/C ratio in cells injected with Ezrin-RFP mRNA only, or co-injected 
with dsTead4, dsTfap2c+dsTead4 RNAs. Data shown as individual data points with Box and 
Whiskers plot (bottom: 25%; upper: 75%; line: median; whiskers: min to max). n=20 cells for 
Ezrin-RFP only; n=18 cells for dsTead4; n=27 cells for dsTfap2c+dsTead4. N=2 independent 
experiments. ****p<0.0001. One-way ANOVA test. (C) Representative images of embryos 
microinjected with Ezrin-RFP mRNA only, Tead4 and Tead4+Tfap2c mRNAs and analysed 
for YAP localisation at the early 8-cell stage. Arrows indicate cells overexpressing Tead4. (D) 
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Quantification of YAP N/C ratio in cells microinjected with Ezrin-RFP mRNA only; with 
Tead4; or with Tfap2c+Tead4 mRNAs. Data shown as individual data points with Box and 
Whisker plots (lower: 25%; upper: 75%; line: median; whiskers: min to max). n=20 cells for 
each group. ****p<0.0001, one-way ANOVA test. Scale bars, 15µm. 
 
 
4.9 Overexpression of Tfap2c/Tead4/RhoA triggers premature apical domain 
formation 
  
4.9.1 Overexpression of Tfap2c, with or without Tead4, triggers membrane protrusion 
and premature compaction at the late 4-cell stage.  
To fully dissect the role Tfap2c and Tead4 on the timing of cell polarity formation at the 8-cell 
stage, it is essential to evaluate the effects of advancing the timing of Tfap2c and Tead4 
expression on the establishment of cell polarity. To this end, overexpression of Tfap2c and 
Tead4 was performed. In the first instance, the concentration of each transcription factor was 
tested (200ng/ul, 100ng/ul, 15ng/ul). It was noted that the high concentration of Tfap2c (equal 
or above 30ng/ul) caused developmental arrest in a cell-autonomous manner (Figure 4.16A), 
yet the overexpression of Tead4 at equal concentrations exhibited no phenotype (data not 
shown).  
 




Figure 4.16 A high concentration of Tfap2c leads to cell division defects. (A) Embryos 
overexpressing Ezrin only (as a control) or 30ng/ul Tfap2c were fixed at the morula stage and 
stained for Pard6, F-actin and DAPI. The embryos overexpressing Tfap2c fail to proliferate 
and have only 4 blastomeres at the morula stage. Scale bars, 15µm. 
   
When Tfap2c was expressed at a low concentration (15ng/ul), this triggered membrane 
protrusion-like structures, accompanied by premature cell compaction (Figure 4.17A-D). At 
the late 8-cell stage, the cells failed to form a proper apical domain but instead they formed 
protrusion like structures (Figure 4.17), similar to those observed at the late 4-cell stage. 
Furthermore, in subsequent cell divisions these cells were engulfed to the inside of the embryo 
(Figure 4.17).   




Figure 4.17 Overexpression of Tfap2c or Tfap2c+Tead4 lead to the formation of 
membrane protrusion like structures at the late 4-cell stage and premature compaction 
events. (A-D) Time-lapse imaging of embryos overexpressing Ezrin-RFP only (A), or co-
expressing Tead4 (B), Tfap2c (C) and Tfap2c+Tead4 (D). Arrows indicate apical domain 
formation already at the late 4-cell stage. (E) Quantification of the percentage of cell 
compaction in the various overexpression conditions at the late 4-cell stage.  Data are shown 
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as a contingency table, the numbers in each bar indicate the numbers of embryos analysed. (F) 
Embryos overexpressing Ezrin-RFP (as a control) or Tfap2c+Tead4 were fixed at the morula 
stage and stained for Pard6, F-actin and Ezrin. Arrows indicate membrane protrusion structures. 
N=3 independent experiments.  Scale bars, 15µm. 
 
To better understand the extent to which the membrane protrusions induced by Tfap2c/Tead4 
overexpression are associated with apical domain formation, the cells were fixed at the late 4-
cell stage and immunostained for apical proteins such as Pard6. This revealed that the structures 
were composed of apical domain proteins, such as Ezrin and Pard6 (Figure 4.18). Additionally, 
the dynamics forming such structures were filmed by time-lapse imaging, and compared with 
normal apical domain formation processes. Results in the previous chapter indicate that normal 
polarisation processes consist of two major steps. The first step, is the actomyosin complex 
polarisation, followed by apical protein enrichment and the ring domain formation (See 
Chapter III, results). A detailed analysis of the apical domain formation revealed that, the 
second step of apical domain formation can be further sub-divided into 2 distinct stages. In 
stage I, the apical proteins are enriched at the centre of a cell and in stage II, the primary apical 
domain expands to a proportion of the cell contact-free surface to form a ring-like structure. In 
the case of Tfap2c and Tead4 overexpression, although the apical enrichment process did occur 
(step 1, as well as the first stage of step 2) the apical domain expansion did not, but instead the 
apical domain proteins continued to be concentrated at the centre of the cell contact-free surface 
ultimately resulting in the formation of membrane protrusions (Figure 4.18). 




Figure 4.18 Tfap2c and Tead4 overexpression induces apical domain centralisation 
without apical domain expansion. (A) Embryos overexpressing Ezrin only (as a control) or 
Tfap2c+Tead4 were fixed at the late 4-cell stage and stained for Pard6. (B) Snapshots of the 
time-lapse imaging of embryos expressing LifeAct and Ezrin-RFP during the 8-cell stage of 
development.  Arrows indicate the direction of the apical protein movements. (C) Plotting of 
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the Ezrin-RFP signal during the apical domain centralisation step. (D) Plotting of the Ezrin-
RFP signal during the apical domain expansion step. (E) Snapshots of Ezrin dynamics in 
embryos overexpressing Ezrin only (as a control) or Tfap2c+Tead4. Scale bars, 15µm. 
  
A detailed analysis through time-lapse imaging, together with the immunostaining results 
suggested that Tfap2c/Tead4 overexpression may promote specific processes of apical domain 
formation, yet the two factors were not sufficient to trigger apical domain formation. It is clear 
that other critical factors are necessary for the construction of a complete apical domain.  
  
4.9.2 Actin regulators are activated by Tfap2c and Tead4 and are regulating apical 
domain concentration step 
The examination of Tfap2c and Tead4 knockdown embryos revealed that the cells depleted of 
Tfpa2c and Tead4 failed to undergo the apical domain centralisation steps, although the 
embryos were able to undergo compaction. A complete understanding of the regulation of the 
apical domain centralisation process by Tfap2c and Tead4 requires the identification of their 
key downstream targets.  
 
The apical domain protein centralisation and expansion process highly resembles T-cell 
receptor activation. In this system, the activated T-cell receptors first cluster together and 
subsequently exclude actin to the periphery. The entire process is regulated by dynamic actin 
cytoskeleton movements that require sufficient levels of Arp2/3, Cofilin/ADF factors, profilin 
and myosin contractility. Interestingly, all the above factors are dramatically upregulated 
during the 4-8 cell stage of development, including the Arp2/3 complex component 
Arpc2/3/4/5; Cofilin/ADF factors Cfl1,2 and Dstn; Pfn1 (Profilin) and Myosin light chain 
Myl12b. These complexes have been implicated in different systems as generally involved in 
regulating actin network dynamics. Specifically, Arp2/3 complex, the major components of 
which are Arp2 and Arp3, is responsible for the actin branching process (Pollard, 2007); 
Cofilin/ADF factors are necessary for actin severing (Bamburg and Bernstein, 2010); Profilin 
is an actin binding protein that mediates the actin turn-over process in general (Krishnan and 
Moens, 2009); Myosin light chain is part of the myosin II complex that is important for actin-
myosin contractility (Heissler and Sellers, 2014). To investigate whether Tfap2c and Tead4 
could account for the upregulation of the above factors, the expression level of those genes was 
determined by qPCR in the embryos injected with dsGFP or dsTfap2c+dsTead4. The results 
showed that Cfl1, Dstn, Aprc5 and Pfn1 were downregulated upon knockdown of Tfap2c and 
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Tead4 at the early 8-cell stage, suggesting that Tfap2c and Tead4 account for their upregulation 
between the 4-8 cell stage. More importantly, the inhibition of the Arp2/3 complex by CK666, 
and Cofilin phosphorylation by Limki-3 equally abolished the apical domain protein 
centralisation steps (Figure 4.19), suggesting that the regulation of the Arp2/3 complex proteins 
and Cofilin may be the major downstream mechanism for the Tfap2c/Tead4 mediated apical 
domain centralisation step.  
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Figure 4.19 Cofilin/ADF factors and the Arp2/3 complex mediate the apical domain 
centralisation step downstream of Tfap2c and Tead4. (A) Snapshots of the time-lapse 
movie showing UtrCH-mCherry dynamics in embryos injected with dsGFP (control) or 
dsTfap2c+dsTead4. In dsGFP injected embryos (control), during the mid to late 8-cell stage, 
apical polarity proteins become centralised at the cell-contact free surface, and exclude actin 
to the periphery of apical protein enriched domain to form the apical cap. Embryos depleted of 
Tfap2c and Tead4 fail to undergo such actin rearrangements as the actin distribution remain 
homogeneous in cell-contact free surface. (B) Heatmap showing expression profile of various 
actin regulators from the zygote to the 32-cell stage in the single-cell RNA sequencing dataset 
(Goolam et al., 2016). (C) Expression level of Pfn1, Arpc5, Cfl1 and Dstn in embryos injected 
with dsGFP (control) and dsTfap2c+dsTead4. Data are shown as mean ± S.E.M.  (D) Snapshots 
of the dynamics of Ezrin-RFP in the embryos treated with DMSO (control) and Limki-3 
(Cofilin phosphorylation inhibitor). (E) Embryos treated with DMSO or Limki-3 were fixed at 
the late 8-cell stage and stained for Pard6 and F-actin. (F) Embryos treated with DMSO or 
CK666 were fixed at the late 8-cell stage and stained for Pard6 and F-actin. (G) Quantification 
of apical Pard6 enrichment. Each dots represent an analysed cell. ****p<0.0001, student’s t-
test. N=8 embryos for DMSO, N=12 embryos for Limki-3 and N=8 embryos for CK666 treated 
group. N=2 independent experiments. Scale bars, 15µm. 
 
 
4.9.3 Co-overexpression of Tfap2c, Tead4 and RhoA accelerates the morphogenetic 
events related to apical domain establishment. 
Studies in other systems have suggested that the Arp2/3 complex regulated actin cap domain 
expansion can be modulated by actomyosin tension downstream of RhoA-ROCK activity 
(Zenker et al., 2018; Zhang et al., 2018).  In support of this, the overexpression of constitutively 
activated RhoA (RhoA-Q63L) led to apical domain expansion all around the cell membrane at 
the late 8-cell stage (Figure 4.20A,C). It has also been observed that the RhoA-Q63L 
overexpression can interfere with cytokinesis processes and led to the bi-nucleation, and affect 
the formation of blastocyst structures at E3.5 (data not shown). On the contrary, the inhibition 
of RhoA by C3-transferase led to the formation of membrane protrusions that resembled those 
induced by Tfap2c+Tead4 overexpression (Figure 4.20B). These results raised the possibility 
that RhoA could function specifically at the apical domain expansion step. To address this 
possibility, the co-overexpression of Tfap2c/Tead4 and RhoA were performed. A series of 
RhoA-Q63L concentrations were tested for RhoA-Q63L co-overexpression experiments. It 
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was observed that a high dose of RhoA caused the membrane disorganisation in nearly all cells 
(data not shown), yet when a fairly low concentration of RhoA-Q63L (3ng/ul) was introduced 
to the early 4-cell stage cells together with Tead4/Tfap2c, this triggered an apical like domain 
formation at the late 4-cell stage to the early 8-cell stage (Figure 4.21). In contrast, RhoA-Q63L 
alone, at the same concentration led to either membrane disorganisation, or no phenotype 




Figure 4.20 RhoA regulates the apical domain size. (A) The overexpression of constitutively 
active RhoA led to apical domain expansion at the morula stage. (B) RhoA inhibition by C3-
transferase treatment led to the formation of membrane protrusions enriched by apical domain 
proteins at the late 8-cell stage. Arrows indicate the apical protrusions. Squares indicate the 
magnified regions. (C) Quantifications of apical domain size of various conditions. Each dots 
represents an analysed cell. N=8 embryos for Ezrin only; N=8 embryos for Tfap2c; N=10 
embryos for Tead4; N=13 embryos for Tfap2c+Tead4; N=7 embryos for RhoA-Q63L; N=15 
embryos for Tfap2c+Tead4+RhoA-Q63L. Scale bars, 15µm. 
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A close examination of time-lapse studies revealed that the dynamics of formation of these 
apical domain-like structures were very similar to those of apical domain assembly in the late 
8-cell stage embryo. They led to the apical polarisation of both Ezrin and Pard6 (Figure 4.21A-
B) and the induction of the differentiation marker Cdx2 (Figure 4.21C-D), suggesting that 
Tfap2c/Tead4/RhoA are sufficient to advance cell polarisation. 
  
Together, these results suggest that Tfap2c/Tead4, and a concomitant increase of Rho activity 
are sufficient to induce apical domain formation, thus they are likely the major components 
constituting the timer for cell polarity establishment at the 8-cell stage. 





Figure 4.21 RhoA-Q63L together with Tfap2c and Tead4 overexpression led to the 
formation of a premature apical domain. (A) Scheme of Tfap2c, Tead4, RhoA 
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overexpression and representative time-lapse snapshots of Ezrin-Venus dynamics during the 
formation of apical domain structures in 1) natural embryos at late 8-cell stage (from Ezrin-
Venus only control group); 2) cells over-expressing Tfap2c+Tead4 showing induced apical 
domain structure at the late 4-cell stage; 3) cells over-expressing RhoA-Q63L showing 
membrane protrusion at the late 4-cell stage; 4) cells over-expressing Tfap2c+Tead4+RhoA-
Q63L showing induced premature apical domain structure at the late 4-cell stage. Short arrows 
indicate Ezrin-Venus enrichment at the cell contact-free surface.  Long arrows indicate the 
expansion direction of the Ezrin-Venus enclosed ring domain. Squares indicate the zoomed-in 
region of each embryo. (B) Quantification of structures induced by various overexpression 
conditions. Data presented as a stacked bar graph where numbers in each bar indicate the 
number of cells analysed. (C) Representative images of embryos overexpressing Ezrin-RFP 
(control) and Tfap2c/Tead4/RhoA-Q63L at the mid 8-cell stage immunostained to reveal DNA, 
Cdx2 and Pard6.  Injected cells (arrows) express Ezrin-GFP (n=8 embryos). (D) Quantification 
of normalised Cdx2 expression signal intensity in either cells injected with Ezrin-RFP or 
withTfap2c/Tead4/RhoA-Q63L mRNAs as in a. Intensity of Cdx2 expression in cells of each 
group is normalised to intensity of DAPI (DNA) staining and for each group injected cells were 
normalised against non-injected cells.  Each dot represents a single embryo. N=5 independent 
experiments. *p=0.0286, Mann-Whitney test. Overexpression of Tfap2c/Tead4/RhoA-Q63L 






4.10 Tfap2c/Tead4/RhoA co-overexpression accelerated the morphogenetic 
program in the preimplantation mouse embryo 
The results that Tfap2c/Tead4/RhoA activity together can induce premature apical domain 
formation also provided an opportunity to address whether the timing of apical domain 
formation is associated with other morphogenetic events taking place at the preimplantation 
stage, including apical domain zippering with tight junctions (Zenker et al., 2018), and 
cavitation events.  
  
To this end, long-term time-lapse imaging running from the late 4-cell stage to the early 
blastocyst stage (E3.5) was performed. This revealed that, in the cells that established the apical 
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domain earlier (late 4-cell stage), the apical domain zippering process was accelerated and took 
place at the late 8-cell stage, instead of the early 16-cell stage as normal (Figure 4.22). 
Moreover, the premature zippering process was linked to tight junction formation, as the 
zippering sites were enriched by ZO-1 (Figure 4.22).  
  
These results suggest that Tfap2c/Tead4/RhoA overexpression can accelerate the overall 
morphogenetic events in the preimplantation mouse embryo, and that the timing of apical 
domain formation may set the timer for apical domain zippering and contribute to tight junction 
formation processes (Figure 4.23). 
 
  




Figure 4.22 RhoA, Tfap2c, Tead4 overexpression led to premature apical domain 
formation and accelerated the following morphogenetic events. (A) Representative image 
of a control embryo expressing Ezrin-RFP at the late 8-cell stage (n=12 embryos). (B) 
Representative images of apical domain zippering in embryos overexpressing 
Tfap2c/Tead4/RhoA-Q63L at the late 8-cell stage (n=24 embryos). Pink and Yellow 
rectangular outlines indicate different magnified regions (below). Coloured arrows indicate 
boundaries of apical domains in different cells. (C) Representative images of embryos 
overexpressing Ezrin-RFP (control) and Tfap2c/Tead4/RhoA-Q63L at the late 8-cell stage 
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stained to reveal Pard6 and tight junction marker, ZO-1 (n=8 embryos for Ezrin only, n=12 
embryos for Tfap2c/Tead4/RhoA-Q63L). Magnified regions are outlined. Arrows indicate the 
point of convergence of the apical domain and the tight junction. Tfap2c/Tead4/RhoA-Q63L 
overexpression advances apical domain formation and accelerates the expansion of the apical 





Figure 4.23 Model of the timer regulating polarity formation in the 8-cell stage mouse 
embryo. The “hourglass” timing model for establishment of de novo cell polarisation in the 
mouse embryo as a transcriptional cascade initiated by zygotic genome activation. Zygotic 
transcripts for Tfap2c and Tead4 gradually accumulate from the 2- to 8-cell stage. Tead4 
expression spontaneously induces nuclear localisation of YAP promoting the Tead4-YAP 
transcriptional machinery. Tfap2c and Tead4-YAP induced transcriptional activity, including 
key actin regulators such as Arp2/3 complex components and Cofilin/ADF factors, drives the 
central enrichment of apical domain components; Rho protein activity facilitates expansion of 





4.11.1 Re-examination of “inhibitor hypothesis”: is cell polarity driven by the 
degradation of inhibitor(s) or the accumulation of zygotic activator(s)? 
Given the importance of cell polarity in preimplantation development, coupled with the 
intriguing fact that mammalian embryos display cellular polarisation at a relatively late 
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embryonic stage, the mechanism governing the timing of cell polarisation in the mouse has 
been a topic of study for decades due in part to its far-reaching medical implications. The 
influential inhibitor hypothesis describes that, the constituents required for cell polarity 
establishment are already stored at sufficient levels prior to the early 4-cell stage, after which 
time the barrier for the establishment of cellular polarisation is purely attributed to potential 
“inhibitors”, and the degradation of these inhibitors allows cell polarity to take place. This 
hypothesis originated form an early experiment in which protein synthesis inhibitors were 
applied from the late 2-cell stage or the early 4-cell stage, as a result of which the authors 
consistently observed premature flattening (compaction), and in many cases, precocious 
cellular polarisation examined by glycoprotein distribution (Concanavalin A immunostaining). 
However, these observations were not supported by the results in the current study, as cell 
polarity was examined by the more commonly used markers Pard6 and F-actin. It is fairly 
challenging to explain the discrepancies between the results, as with time, the culture medium, 
the methods for drug purification and the mouse strains have changed substantially. Despite 
the fact that protein synthesis inhibitors gave similar phenotypes in embryos of different 
genetic backgrounds (author’s observations), it is possible that the response of the embryos to 
the drug varies with culture medium. Keeping all experimental conditions identical to the early 
studies is not practically feasible.  However, it is important to note that although the current 
results are not sufficient to exclude the potential existence of polarity inhibitors, they provide 
lines of evidence that strengthen the argument for presence of polarity activators, and reveal 
the nature of these. Results from the bisection experiments are implicative rather than decisive 
(as will be discussed later), yet the transcription inhibitor treatments provide a stronger 
argument that zygotic transcriptional events contribute factors that positively regulate/are 
necessary for cell polarity establishment. Moreover, the identification of two transcription 
factors Tfap2c and Tead4, the protein of which is majorly contributed by ZGA, as necessary 
and partially sufficient factors for cell polarity establishment further strengthens the hypothesis 
that cell polarity establishment requires activators produced by zygotic transcription. It is 
unclear whether specific polarity inhibitors (acting on important cytoskeleton regulators) are 
provided by zygotic genome activation, however it is well-established that maternal protein 
degradation constitutes an important permissive signal for zygotic genome activation. From 
this perspective protein degradation may be one of the necessary conditions for cell polarity 
establishment, although the effects could be indirect. A more genome-wide genetic screen 
approach may aid in the identification of the nature of potential “polarity inhibitors”.  
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4.11.2 Blastomere resection experiment implicates a role for zygotic RNA 
concentration in the determination of the timing of cell polarity. 
To test the possibility that the zygotic RNA concentration sets the threshold that triggers the 
timing of cell polarity, the blastomere resection method was used to reduce the cytoplasmic 
size. RNA concentration is correlated with cytoplasm volume (Padovan-Merhar et al., 2015) 
and particularly, the reduced cytoplasm size has been shown to lead to a higher RNA 
concentration. However, the blastomere resection procedure per se may have other effects 
independent of RNA concentration. For example, the reduction of cytoplasm volume increases 
the nuclear/cytoplasm (N/C) ratio, a factor that has been implicated in regulating early 
developmental transitions in other systems (Blythe and Wieschaus, 2015; Collart et al., 2013). 
However, the N/C ratio is not likely to play a role in determining the timing of cell polarisation, 
as the prevention of cell cycle by microtubule inhibitors such as nocodazole and colcemid, or 
DNA replication inhibitors does not significantly affect the timing of cell polarisation (Pratt et 
al., 1982; Smith and Johnson, 1985). A second possible effect is the increase in cortical tension 
due to the reduction in cell size. This is also unlikely to explain the effect of blastomere 
resection on the timing of cell polarisation, as the blebbistatin treatment experiment (Chapter 
III) suggested that cortical tension does not directly regulate cell polarity, despite its role in 
driving cell compaction.  
 
Nevertheless, many unknown transcriptional effects could potentially accompany the reduction 
of cell size, and directly separating these from the effect of RNA concentration could prove 
challenging. Therefore to unequivocally verify the effect of RNA concentration on the timing 
of polarisation, the resected cells were treated with DRB to inhibit transcription. Upon DRB 
treatment the timing of cell polarisation in resected cells was not significantly different from 
the control (non-resected) sister cells, strongly suggest that the effects on the timing of 
polarisation observed in the absence of DRB treatment were due to transcription related events.  
 
Another intriguing observation was that the alteration of cytoplasmic volume at the 4-cell stage 
seemed to cause a more severe phenotype than at the 2-cell stage. This effect could potentially 
be due to the adaptability of the cells to the altered cellular volume. It has been observed in a 
variety of cells lines in many species that cells can adapt to changes in cytoplasmic volume 
through feedback mechanisms regulating chromatin gene expression, although on the whole, 
mathematical modelling predicts that the decrease in cell size results in a higher concentration 
of RNA. This suggests that the cells may respond to the resection by upregulating factors that 
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are sensitive to cell volume. Presumably, this adaptation response is triggered immediately 
after the resection, and with time the effects of gene dosage compensation become more and 
more evident. Thus, the nearer the resection is performed to cell polarity establishment, the 
stronger the effect.  To fully verify whether gene dosage compensation takes place as a result 
of the resection, a more direct method to visualise single RNA molecules such as single RNA 
fluorescence in situ hybridization could be applied.  
   
4.11.3 Transcription factor Tfap2c and Tead4 activity is required for cell polarity 
establishment.  
Transcription factors with a high activity at the 8-cell stage were screened by RNAi knockdown 
experiments. Tfap2c and Tead4 were identified as potential regulators of cell polarity 
formation, as the knockdown of each of them impaired apical domain formation, while their 
co-depletion resulted in a more pronounced phenotype. One important matter to address is the 
identification of the downstream factors of Tfap2c/Tead4 which are responsible for triggering 
cell polarity establishment. The results in Chapter III demonstrate a detailed dissection of the 
signalling pathways responsible for cell polarity establishment, out of which the actin 
cytoskeleton dynamics, driven by various actin re-modellers, seem to be critical. A Chip-seq 
analysis of both transcription factors has been performed in the context of Trophoblast stem 
cells (Choi et al., 2013; Home et al., 2012). The analysis of the binding domains and potential 
downstream targets of both factors revealed several actin cytoskeleton regulators, such as Cfl1, 
Dstn, Marcksl1; and several Rho GTPases regulators, such as Arhgap8, Arhgap17, Arhgap19, 
Arhgef12, Arhgef18. Preliminary RNAi experiments in which each of the above candidates 
was knocked down failed to give a strong polarity phenotype as compared to the depletion of 
Tfap2c or Tead4, yet the dsRNAs’ efficacy requires further assessment. Nevertheless, the 
strategy of screening downstream targets of Tfap2c/Tead4 based on Chip-seq analysis is 
limited. A potential scenario in which polarity defects are a result of secondary effects (i.e. 
Tfap2c/Tead4 mediated activation of other transcription factors which in turn activate polarity 
regulators) would be omitted in this approach. In this regard, the analysis of the global 
transcriptome changes upon the depletion of Tfap2c and/or Tead4 may be more appropriate. 
Furthermore, the determination of global transcriptome changes may have other advantages. 
For example, transcription factors can induce specific morphogenetic changes often via 
multiplex downstream factors which act in concert, instead of relying on a single target 
(Moroishi et al., 2015; Shahbazi et al., 2017). This is highly likely to be true for the case of 
Tfap2c/Tead4. Therefore, the determination of global gene expression changes could result in 
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a more accurate estimate of the effect on the cytoskeleton or cellular morphology, with the help 
of a quantitative mathematical model.  
 
The precise role of Tfap2c/Tead4 in establishing the apical domain remains unclear, yet the 
overexpression experiments indicate that they may promote actin cytoskeleton reorganisation. 
Results in Chapter III suggest that the first step in apical domain assembly requires a polarised 
and activated actomyosin system that is regulated by the PKC-Rho GTPase signalling axis. 
This is followed by apical polarity protein recruitment, concentration and further the expansion 
of apical domain. The overexpression of Tfap2c/Tead4 triggered membrane protrusion-like 
structures enriched by apical polarity proteins such as Pard6 and Ezrin (Figure 4.18A). A 
detailed examination of the dynamics triggering protrusive structure formation upon 
Tfap2c/Tead4 overexpression revealed that the two factors were linked to the apical domain 
assembly, by the apical protein centralisation step, despite the lack of the apical expansion step. 
It seems therefore that Tfap2c/Tead4 mediated transcription activates compaction, actomyosin 
asymmetry, and the apical domain membrane recruitment and centralisation steps. Although 
Tfap2c/Tead4 overexpression is capable of triggering premature compaction as well as 
actomyosin asymmetry, the two factors do not seem to be necessary for this event, as the 
knockdown or knockout of Tfap2c/Tead4 did not impair cell compaction. As discussed in 
Chapter III, PKC mediated post-translational modifications are necessary and sufficient for cell 
compaction as well as actomyosin asymmetry, thus one possibility would be that Tfap2c/Tead4 
activate cytoskeleton factors that promote PKC activity, yet other pathways can compensate 
for Tfap2c/Tead4’s role in doing so. On the contrary, Tfap2c/Tead4 are absolutely required for 
apical domain protein concentration, supported by the findings that knockdown and knockout 
of Tfap2c/Tead4 abolished the centralisation step (Figure 4.12A), and that the overexpression 
of Tfap2c/Tead4 consistently triggered apical domain protein centralisation and finally 
protrusive structure formation. This result echoes the transcription inhibitor experiments, 
which suggest that the apical domain concentration step requires a proximate transcriptional 
activity. It is highly possible that the factors affected by transcriptional inhibitors are the 
downstream targets of Tfap2c/Tead4.  
 
4.11.4 A genetic interaction between Tfap2c and Tead4 
The single genetic depletion of Tfap2c or Tead4 does not result in a strong cell polarity 
phenotype, yet the concomitant depletion of both factors completely abolished cell polarisation. 
These results suggest a genetic interaction between Tfap2c and Tead4. In an attempt to address 
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the mechanistic importance of such observations two potential possibilities seem reasonable. 
Firstly, Tfap2c and Tead4 may bind to a common downstream target but at different enhancers. 
Both these enhancers may contribute to gene expression, yet the Tfap2c-regulated enhancer 
region could be more effective in triggering gene expression. This could explain why Tfap2c 
loss-of- or gain-of-function experiments all display a stronger phenotype over Tead4. 
Additional evidence could support such an idea: the master TE specifier Cdx2 is a common 
downstream target for both Tfap2c and the Hippo pathway regulated Tead4/Yap complex. Yet 
Tfap2c regulates Cdx2 expression by directly binding to a region within intron 1 of the Cdx2 
genomic locus (Cao et al., 2015), whereas Taed4/Yap regulates the cis-regulatory enhancer of 
Cdx2 upstream of the TSS (Rayon et al., 2014). However, overexpression of Tfap2c induces a 
near 100-fold increase of Cdx2 expression in the embryo (Cao et al., 2015) whereas Tead4/Yap 
overexpression fails to do so (author’s observation). Secondly, it is also possible that Tead4 
compensates for Tfap2c by binding to the same loci, yet its binding is only stabilised once 
Tfap2c is depleted, a mechanism similar to “transcription factor competition” (Domcke et al., 
2015; Karreth et al., 2014). Gene activation is always associated with intricate chromatin 
topology changes, therefore to fully reveal the mechanism of the Tfap2c and Tead4 
collaborative regulation of cell polarisation one would need to acquire information pertaining 
to the changes in chromatin structure of key downstream polarity regulators upon depletion of 
either or both transcription factors. Several recently developed tools for capturing chromatin 
conformation, such as Hi-C or 5C, would be useful in addressing this question.  
 
4.11.5 The molecular panorama of cell polarity establishment at the 8-cell stage 
mouse embryo and its potential implications 
Results in this Chapter address some remaining questions concerning apical domain 
establishment from Chapter III. More importantly, these results provide a demonstration of 
how diverse signals integrated from post-translational modifications and transcription build the 
apical domain at a defined time set during mouse embryogenesis.   
 
Results in Chapter III suggest that an asymmetric and active actomyosin network is the first 
prerequisite for apical domain assembly, yet its role in building the apical domain seems to be 
permissive, as actomyosin alone is insufficient to recruit apical domain proteins, and the 
missing factors only appear around the 8-cell stage (Discussion in Chapter III). The results 
from the current Chapter suggest that such stage dependency relies on the transcriptional input 
from the 4-8 cell stage downstream of transcription factors Tfap2c and Tead4. Specifically, 
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such transcriptional activity allows apical proteins to be recruited to the membrane and 
centralised to a specified region on the cell contact-free surface. Interestingly, RhoA appears 
to play multiple roles during this process. To begin with, in the very first phase of apical domain 
assembly, RhoA acts downstream of PKC to activate the actomyosin network and therefore 
polarises to the apical domain, providing a landmark for apical domain positioning. Secondly, 
at the subsequent phase of apical domain establishment, RhoA helps to expand the apical 
proteins to form an apical cap structure. The detailed mechanism underlying the interplay 
between post-translational activities (PKC, RhoA activity) and transcriptional activity (Tfap2c, 
Tead4/Yap mediated) calls for substantial future study. Particularly, the description of the 
molecular details concerning the input from actomyosin polarisation, Tfap2c/Tead4 and RhoA 
in defining the morphology of the apical domain will be the critical. From the results of gain-
of- and loss-of function experiments of Tfap2c/Tead4 and RhoA, it seems likely that 
Tfap2c/Tead4 and RhoA provide complementary forces for apical domain formation. In other 
words, the transcriptional programme induced by Tfap2c/Tead4 specifically concentrates 
apical domain proteins, whereas RhoA expands these proteins, and the competition between 
these two components defines the dynamics of apical domain formation as well as the size of 
the apical domain.  However the determination of the precise manner in which Tfap2c/Tead4 
and RhoA work will require a better understanding of the way in which each factor affects the 
cytoskeleton environment and apical protein dynamics. In addition, the role of PKC-mediated 
actomyosin polarisation in this process will need to be better defined. The regulation of apical 
protein recruitment and the acquisition of a specific polarised pattern are central to cell polarity 
studies. The finding that PKC, Tfap2c/Tead4, and RhoA induce the self-organisation of apical 
domain proteins into a limited region provides an opportunity for these important topics to be 
addressed.




The establishment of cell polarity is an important prerequisite for mouse embryo development. 
It drives the transcriptional direction of outside cells to the acquisition of a trophectodermal 
fate and structurally prompts the entire epithelisation process including tight junction 
maturation and blastocoel formation (Alarcon, 2010; Watson et al., 1990; Zenker et al., 2018). 
Intriguingly, unlike many other model systems, cell polarity in the mouse embryo arises from 
a specific developmental stage. The timeframe of cell polarity establishment is closely 
associated with normal developmental progression, as the experimental perturbation of this 
timing leads to the alteration of embryonic and extra-embryonic lineage ratios (Johnson et al., 
1979). Despite decades of study, the effect of timing in the regulation of cell polarisation in the 
mouse embryo remains poorly understood, as the detailed molecular pathways that trigger cell 
polarity establishment are largely unclear, and the extent of its reliance on parallel cellular 
processes, such as transcription and translation is undetermined. With the ultimate aim of 
understanding the timing regulation of cell polarity establishment, two different strategies were 
used in this work to tackle this long-standing developmental question.  
 
The results in Chapter III attempted to first characterise the processes driving cell polarity 
establishment in depth. To this end, the dynamics of the cytoskeleton in relation to apical 
proteins were examined in live and fixed samples. This revealed two different phases of cell 
polarity establishment, with the actomyosin complex and apical domain proteins polarising at 
different times. Furthermore, the requirement of cell polarity establishment for generic 
cytoskeletal networks, such as the actomyosin network, was determined by pharmacological 
treatments. The results suggested that actomyosin apical polarisation serves as a scaffold for 
the apical protein recruitment that follows, but that actomyosin contractility is dispensable. The 
subsequent pharmacological screen was performed to determine the regulators associated with 
actomyosin polarisation and permissive for apical domain establishment. This revealed that 
PLC, PKC and RhoA were the critical determinants for actomyosin activation and its apical 
polarisation. The inhibition and activation assays using pharmacological treatments, dominant 
negative forms and overexpression of constitutively active constructs, together with newly 
developed optogenetics methods, revealed the linear relationship between PLC, PKC and 
RhoA in regulating actomyosin apical polarisation. Precisely, PLC activates PKC by PIP2 
hydrolysis, and subsequently PKC activation triggers active RhoA apical polarisation which 
directs actomyosin membrane recruitment via a phosphorylation independent pathway. The 
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fact that actomyosin activation and polarisation happen around the early 8-cell stage implies 
the possibility that it may contribute to the timing regulation of apical domain establishment. 
However, activation of actomyosin prematurely via three different methods suggested that 
actomyosin activation and polarisation per se is insufficient to assemble the apical domains but 
instead other factors are involved in the recruitment and centralisation of the apical domain 
components, and these factors likely appear only around the 8-cell stage.  
 
To reveal the mechanism that defines polarisation timing, and also to identify the missing 
factors complementing actomyosin in building a complete apical domain, a hypothesis-testing 
method was used (discussed in Chapter V) to explore the precise influence of timing on cell 
polarity establishment. A hypothesis whereby zygotic genome activation triggers the 
establishment of cell polarity through the accumulation of positive regulators has been 
proposed. To test this hypothesis, blastomere resection experiments alongside transcription 
inhibitor experiments have been performed. These revealed that cell polarity establishment 
relies on those transcription factors that are actively transcribed until the mid 8-cell stage. 
Moreover, the protein concentration of polarity activators above a specific threshold defines 
the timing of polarity establishment. An RNAi screen was performed to identify the key zygotic 
factors triggering cell polarity establishment. This allowed the detection of two transcription 
factors, Tfap2c and Tead4, as necessary for cell polarity establishment. The proteins levels of 
Tfap2c and Tead4 are steadily upregulated after ZGA up until the morula stage, and are 
responsible for the expression of multiple actin regulators at the early 8-cell stage. RNAi 
mediated knockdown and CRISPR based knockout experiments demonstrated that Tfap2c and 
Tead4 regulate the apical domain proteins’ centralisation and expansion steps, therefore the 
transition from phase I to phase II. This is suggestive of the transcriptional programme 
activated by Tfap2c and Tead4 being responsible for triggering apical domain maturation upon 
actomyosin polarisation. To experimentally test this Tfap2c, Tead4 and constitutively activated 
RhoA were overexpressed at the 4-cell stage, and this indeed triggered the formation of apical 
cap domains that structurally resembled those of the late 8-cell stage, and were capable of 
accelerating the subsequent associated morphogenetic events such as apical domain zippering 
and tight junction formation.  
 
Together, this dissertation provides a detailed explanation of the timing regulation of apical 
domain establishment, which will also aid in the understanding of the temporal regulation of 
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